![Page 1: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/1.jpg)
2018 Aetna Premier Plus Plan
Absorica
Products Affected• ABSORICA
PA Criteria Criteria Details
Covered Uses Severe recalcitrant nodular or cystic acne
Exclusion Criteria
Required Medical Information
Member is enrolled in the FDA iPLEDGE program and, because of significant adverse reactions associated with its use, should be reserved for patients with multiple severe nodular acne who are unresponsive to conventional therapy, including topical acne products and systemic antibiotics
Age Restrictions
Prescriber Restrictions
Coverage Duration
1 year
Other Criteria
QL Criteria 2 capsules Per 1 Day
Notes/References
Annual Review: 02/2017
Revision DatePrior Authorization: August 22, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
1
![Page 2: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/2.jpg)
Abstral
Products Affected• ABSTRAL
PA Criteria Criteria Details
Covered Uses Breakthrough cancer pain, General anesthesia
Exclusion Criteria
Required Medical Information
A documented diagnosis of cancer and concomitant use of long acting opioid therapy or member's resident state or contract state is California and the member is terminally ill
Age Restrictions
Prescriber Restrictions
Coverage Duration
1 year
2018 Aetna Premier Plus Plan01/01/2018
2
![Page 3: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/3.jpg)
PA Criteria Criteria Details
Other Criteria
For coverage of additional quantities, member must meet the following requirements: A Documented diagnosis of cancer and prescription is written by an oncologist or pain specialist, or member is enrolled in a hospice program or meets hospice criteria, or member's resident state or contract state is California and the member is terminally ill, or the patient has signed opioid agreement in support of clinical guidelines by the American Pain Society and the American Academy of Pain Medicine, Healthcare Provider verbal confirmation that an agreement has been signed by the patient meets the criteria requirement.*Exceptions to requiring the signed opioid agreement for additional quantities are only for those patients that have a diagnosis of cancer or that are enrolled in a hospice program and documentation of one of the following: Member has current diagnosis of cancer(*see exception to opioid agreement above) as the primary cause of the pain and is currently on long-acting opioid and is being titrated on the long-acting opioid by physician, and member has tried and failed an adequate trial of two weeks of a single entity or combination pain medication containing an immediate release acting opioid (ex. oxycodone, morphine sulfate oral(Roxanol), oxymorphone(Opana), hydromorphone(Dilaudid), oxycodone/apap(Percocet))
QL Criteria 120 tablets Per 30 Days
Notes/References
Annual Review: 06/2017
Revision DatePrior Authorization: April 25, 2016Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
3
![Page 4: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/4.jpg)
Acetaminophen-Codeine
Products Affected• acetaminophen-codeine
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
4
![Page 5: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/5.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
5
![Page 6: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/6.jpg)
Acetaminophen-Codeine #2
Products Affected• acetaminophen-codeine #2
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
6
![Page 7: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/7.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
7
![Page 8: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/8.jpg)
Acetaminophen-Codeine #3
Products Affected• acetaminophen-codeine #3
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
8
![Page 9: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/9.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
9
![Page 10: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/10.jpg)
Acetaminophen-Codeine #4
Products Affected• acetaminophen-codeine #4
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
10
![Page 11: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/11.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
11
![Page 12: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/12.jpg)
Actemra
Products Affected• ACTEMRA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Actemra.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
12
![Page 13: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/13.jpg)
Actimmune
Products Affected• ACTIMMUNE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/actimmune.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
13
![Page 14: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/14.jpg)
Actiq
Products Affected• ACTIQ
PA Criteria Criteria Details
Covered Uses Breakthrough cancer pain, General anesthesia
Exclusion Criteria
Required Medical Information
A documented diagnosis of cancer and concomitant use of long acting opioid therapy or member's resident state or contract state is California and the member is terminally ill
Age Restrictions
Prescriber Restrictions
Coverage Duration
1 year
2018 Aetna Premier Plus Plan01/01/2018
14
![Page 15: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/15.jpg)
PA Criteria Criteria Details
Other Criteria
For coverage of additional quantities, member must meet the following requirements: A Documented diagnosis of cancer and prescription is written by an oncologist or pain specialist, or member is enrolled in a hospice program or meets hospice criteria, or member's resident state or contract state is California and the member is terminally ill, or the patient has signed opioid agreement in support of clinical guidelines by the American Pain Society and the American Academy of Pain Medicine, Healthcare Provider verbal confirmation that an agreement has been signed by the patient meets the criteria requirement.*Exceptions to requiring the signed opioid agreement for additional quantities are only for those patients that have a diagnosis of cancer or that are enrolled in a hospice program and documentation of one of the following: Member has current diagnosis of cancer(*see exception to opioid agreement above) as the primary cause of the pain and is currently on long-acting opioid and is being titrated on the long-acting opioid by physician, and member has tried and failed an adequate trial of two weeks of a single entity or combination pain medication containing an immediate release acting opioid (ex. oxycodone, morphine sulfate oral(Roxanol), oxymorphone(Opana), hydromorphone(Dilaudid), oxycodone/apap(Percocet))
QL Criteria 120 lozenges Per 30 Days
Notes/References
Annual Review: 06/2017
Revision DatePrior Authorization: April 25, 2016Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
15
![Page 16: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/16.jpg)
Adcirca
Products Affected• ADCIRCA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 2 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
16
![Page 17: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/17.jpg)
Adderall
Products Affected• ADDERALL
QL Criteria 4 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
17
![Page 18: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/18.jpg)
Adderall XR
Products Affected• ADDERALL XR
QL Criteria 2 capsules Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
18
![Page 19: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/19.jpg)
Adempas
Products Affected• ADEMPAS
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 3 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
19
![Page 20: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/20.jpg)
Advate
Products Affected• ADVATE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
20
![Page 21: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/21.jpg)
Adynovate
Products Affected• adynovate
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
21
![Page 22: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/22.jpg)
Adzenys XR-ODT
Products Affected• ADZENYS XR-ODT
QL Criteria 1 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
22
![Page 23: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/23.jpg)
Afinitor
Products Affected• AFINITOR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
23
![Page 24: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/24.jpg)
Afinitor Disperz
Products Affected• AFINITOR DISPERZ
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
24
![Page 25: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/25.jpg)
Afstyla
Products Affected• AFSTYLA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
25
![Page 26: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/26.jpg)
Aldurazyme
Products Affected• ALDURAZYME
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/lysosomal_storage.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
26
![Page 27: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/27.jpg)
Alecensa
Products Affected• ALECENSA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
27
![Page 28: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/28.jpg)
Alphanate/VWF Complex/Human
Products Affected• ALPHANATE/VWF COMPLEX/HUMAN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
28
![Page 29: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/29.jpg)
AlphaNine SD
Products Affected• ALPHANINE SD
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
29
![Page 30: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/30.jpg)
Alprolix
Products Affected• ALPROLIX
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
30
![Page 31: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/31.jpg)
Alunbrig
Products Affected• ALUNBRIG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Alunbrig.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
31
![Page 32: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/32.jpg)
Amnesteem
Products Affected• AMNESTEEM
PA Criteria Criteria Details
Covered Uses Severe recalcitrant nodular or cystic acne
Exclusion Criteria
Required Medical Information
Member is enrolled in the FDA iPLEDGE program and, because of significant adverse reactions associated with its use, should be reserved for patients with multiple severe nodular acne who are unresponsive to conventional therapy, including topical acne products and systemic antibiotics
Age Restrictions
Prescriber Restrictions
Coverage Duration
1 year
Other Criteria
QL Criteria 2 capsules Per 1 Day
Notes/References
Annual Review: 02/2017
Revision DatePrior Authorization: August 22, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
32
![Page 33: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/33.jpg)
Amphetamine-Dextroamphet ER
Products Affected• amphetamine-dextroamphet er
QL Criteria 2 capsules Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
33
![Page 34: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/34.jpg)
Amphetamine-Dextroamphetamine
Products Affected• amphetamine-dextroamphetamine
QL Criteria 4 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
34
![Page 35: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/35.jpg)
Ampyra
Products Affected• AMPYRA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/Ampyra.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 2 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
35
![Page 36: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/36.jpg)
APAP-Caff-Dihydrocodeine
Products Affected• apap-caff-dihydrocodeine oral capsule• apap-caff-dihydrocodeine oral tablet 325-30-
16 mg
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
36
![Page 37: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/37.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
37
![Page 38: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/38.jpg)
Aptensio XR
Products Affected• APTENSIO XR
QL Criteria 1 capsule Per 1 Day
Notes/References
Annual Review: 05/2017
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
38
![Page 39: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/39.jpg)
Aralast NP
Products Affected• ARALAST NP
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/Alpha-1 Antitrypsin Inhibitor Therapy.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
39
![Page 40: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/40.jpg)
Aranesp (Albumin Free)
Products Affected• ARANESP (ALBUMIN FREE) INJECTION
SOLUTION 10 MCG/0.4ML, 100 MCG/ML, 150 MCG/0.75ML, 200 MCG/ML, 25 MCG/ML, 300 MCG/ML, 40 MCG/ML, 60 MCG/ML
• ARANESP (ALBUMIN FREE) INJECTION
SOLUTION PREFILLED SYRINGE 100 MCG/0.5ML, 150 MCG/0.3ML, 200 MCG/0.4ML, 25 MCG/0.42ML, 300 MCG/0.6ML, 40 MCG/0.4ML, 500 MCG/ML, 60 MCG/0.3ML
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Erythropoiesis_Stimulating_Agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
40
![Page 41: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/41.jpg)
Arcalyst
Products Affected• ARCALYST
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Arcalyst.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
41
![Page 42: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/42.jpg)
Arymo ER
Products Affected• ARYMO ER
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
42
![Page 43: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/43.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Annual Review: 06/2017
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
43
![Page 44: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/44.jpg)
Ascomp-Codeine
Products Affected• ASCOMP-CODEINE
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
44
![Page 45: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/45.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
45
![Page 46: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/46.jpg)
Aspirin-Caff-Dihydrocodeine
Products Affected• aspirin-caff-dihydrocodeine
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
46
![Page 47: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/47.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
47
![Page 48: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/48.jpg)
Atomoxetine HCl
Products Affected• atomoxetine hcl oral capsule 10 mg, 18 mg,
25 mg, 40 mg, 60 mg
QL Criteria 2 capsules Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
48
![Page 49: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/49.jpg)
Atomoxetine HCl
Products Affected• atomoxetine hcl oral capsule 100 mg, 80 mg
QL Criteria 1 capsule Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
49
![Page 50: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/50.jpg)
Aubagio
Products Affected• AUBAGIO
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/Aubagio.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 1 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
50
![Page 51: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/51.jpg)
Austedo
Products Affected• AUSTEDO
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Austedo.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
51
![Page 52: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/52.jpg)
AVINza
Products Affected• AVINZA ORAL CAPSULE EXTENDED
RELEASE 24 HOUR 60 MG
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
52
![Page 53: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/53.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
53
![Page 54: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/54.jpg)
Avonex
Products Affected• AVONEX
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/MSinterferons.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
54
![Page 55: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/55.jpg)
Avonex Pen
Products Affected• AVONEX PEN INTRAMUSCULAR
AUTO-INJECTOR KIT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/MSinterferons.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
55
![Page 56: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/56.jpg)
Avonex Prefilled
Products Affected• AVONEX PREFILLED
INTRAMUSCULAR PREFILLED SYRINGE KIT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/MSinterferons.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
56
![Page 57: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/57.jpg)
Bebulin
Products Affected• BEBULIN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
57
![Page 58: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/58.jpg)
Bebulin VH
Products Affected• BEBULIN VH
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
58
![Page 59: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/59.jpg)
Belbuca
Products Affected• BELBUCA
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
59
![Page 60: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/60.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
60
![Page 61: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/61.jpg)
BeneFIX
Products Affected• BENEFIX INTRAVENOUS SOLUTION
RECONSTITUTED
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
61
![Page 62: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/62.jpg)
Benlysta
Products Affected• BENLYSTA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/benlysta.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
62
![Page 63: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/63.jpg)
Berinert
Products Affected• BERINERT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/hereditary_angioedema.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
63
![Page 64: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/64.jpg)
Betaseron
Products Affected• BETASERON SUBCUTANEOUS KIT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/MSinterferons.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 15 vials Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
64
![Page 65: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/65.jpg)
Bexarotene
Products Affected• bexarotene
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Targretin.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
65
![Page 66: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/66.jpg)
Bivigam
Products Affected• BIVIGAM
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/ivig.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
66
![Page 67: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/67.jpg)
Bosulif
Products Affected• BOSULIF
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 1 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
67
![Page 68: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/68.jpg)
Botox
Products Affected• BOTOX
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/botulinum_toxin.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
68
![Page 69: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/69.jpg)
Bravelle
Products Affected• BRAVELLE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/infertility.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
69
![Page 70: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/70.jpg)
Bunavail
Products Affected• BUNAVAIL BUCCAL FILM 2.1-0.3 MG
QL Criteria 6 films Per 1 Day
Notes/References
Annual Review: 04/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
70
![Page 71: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/71.jpg)
Bunavail
Products Affected• BUNAVAIL BUCCAL FILM 4.2-0.7 MG
QL Criteria 3 films Per 1 Day
Notes/References
Annual Review: 04/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
71
![Page 72: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/72.jpg)
Bunavail
Products Affected• BUNAVAIL BUCCAL FILM 6.3-1 MG
QL Criteria 2 films Per 1 Day
Notes/References
Annual Review: 04/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
72
![Page 73: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/73.jpg)
Buphenyl
Products Affected• BUPHENYL ORAL POWDER 3 GM/TSP • BUPHENYL ORAL TABLET
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/metabolic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
73
![Page 74: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/74.jpg)
Buprenorphine
Products Affected• buprenorphine
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
74
![Page 75: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/75.jpg)
QL Criteria 4 patches Per 28 Days
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
75
![Page 76: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/76.jpg)
Buprenorphine HCl
Products Affected• buprenorphine hcl sublingual
QL Criteria 3 tablets Per 1 Day
Notes/References
Annual Review: 04/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
76
![Page 77: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/77.jpg)
Buprenorphine HCl-Naloxone HCl
Products Affected• buprenorphine hcl-naloxone hcl
QL Criteria 90 tablets Per 30 Days
Notes/References
Annual Review: 04/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
77
![Page 78: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/78.jpg)
Butalbital-APAP-Caff-Cod
Products Affected• butalbital-apap-caff-cod
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
78
![Page 79: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/79.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
79
![Page 80: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/80.jpg)
Butalbital-ASA-Caff-Codeine
Products Affected• butalbital-asa-caff-codeine
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
80
![Page 81: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/81.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
81
![Page 82: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/82.jpg)
Butorphanol Tartrate
Products Affected• butorphanol tartrate nasal
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
82
![Page 83: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/83.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
83
![Page 84: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/84.jpg)
Butrans
Products Affected• BUTRANS
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
84
![Page 85: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/85.jpg)
QL Criteria 4 patches Per 28 Days
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: October 04, 2017
2018 Aetna Premier Plus Plan01/01/2018
85
![Page 86: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/86.jpg)
Cabometyx
Products Affected• CABOMETYX
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
86
![Page 87: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/87.jpg)
Capecitabine
Products Affected• capecitabine
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
87
![Page 88: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/88.jpg)
Capital/Codeine
Products Affected• CAPITAL/CODEINE
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
88
![Page 89: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/89.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
89
![Page 90: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/90.jpg)
Caprelsa
Products Affected• CAPRELSA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
90
![Page 91: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/91.jpg)
Carbaglu
Products Affected• CARBAGLU
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/metabolic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
91
![Page 92: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/92.jpg)
Carimune NF
Products Affected• CARIMUNE NF INTRAVENOUS
SOLUTION RECONSTITUTED 12 GM, 6 GM
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/ivig.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
92
![Page 93: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/93.jpg)
Cerdelga
Products Affected• CERDELGA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/gaucher_disease.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 2 caps Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
93
![Page 94: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/94.jpg)
Cerezyme
Products Affected• CEREZYME
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/gaucher_disease.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
94
![Page 95: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/95.jpg)
Cetrotide
Products Affected• CETROTIDE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/infertility.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
95
![Page 96: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/96.jpg)
Cholbam
Products Affected• CHOLBAM
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Cholbam.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
96
![Page 97: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/97.jpg)
Chorionic Gonadotropin
Products Affected• chorionic gonadotropin intramuscular
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/infertility.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
97
![Page 98: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/98.jpg)
Cimzia
Products Affected• CIMZIA SUBCUTANEOUS KIT 2 X 200
MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Cimzia.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 1 kit Per 1 month
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
98
![Page 99: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/99.jpg)
Cimzia Prefilled
Products Affected• CIMZIA PREFILLED
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Cimzia.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 1 kit Per 1 month
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
99
![Page 100: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/100.jpg)
Cimzia Starter Kit
Products Affected• CIMZIA STARTER KIT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Cimzia.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 1 kit Per 1 year
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
100
![Page 101: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/101.jpg)
Cinqair
Products Affected• CINQAIR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/RESP/Cinqair.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
101
![Page 102: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/102.jpg)
Cinryze
Products Affected• CINRYZE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/hereditary_angioedema.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
102
![Page 103: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/103.jpg)
Claravis
Products Affected• CLARAVIS
PA Criteria Criteria Details
Covered Uses Severe recalcitrant nodular or cystic acne
Exclusion Criteria
Required Medical Information
Member is enrolled in the FDA iPLEDGE program and, because of significant adverse reactions associated with its use, should be reserved for patients with multiple severe nodular acne who are unresponsive to conventional therapy, including topical acne products and systemic antibiotics
Age Restrictions
Prescriber Restrictions
Coverage Duration
1 year
Other Criteria
QL Criteria 2 capsules Per 1 Day
Notes/References
Annual Review: 02/2017
Revision DatePrior Authorization: August 22, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
103
![Page 104: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/104.jpg)
CloNIDine HCl ER
Products Affected• clonidine hcl er
QL Criteria 4 tablets Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
104
![Page 105: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/105.jpg)
Coagadex
Products Affected• COAGADEX
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
105
![Page 106: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/106.jpg)
Codeine Sulfate
Products Affected• codeine sulfate oral tablet
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
106
![Page 107: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/107.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
107
![Page 108: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/108.jpg)
Cometriq (100 mg Daily Dose)
Products Affected• COMETRIQ (100 MG DAILY DOSE)
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
108
![Page 109: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/109.jpg)
Cometriq (140 mg Daily Dose)
Products Affected• COMETRIQ (140 MG DAILY DOSE)
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
109
![Page 110: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/110.jpg)
Cometriq (60 mg Daily Dose)
Products Affected• COMETRIQ (60 MG DAILY DOSE)
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
110
![Page 111: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/111.jpg)
Concerta
Products Affected• CONCERTA ORAL TABLET EXTENDED
RELEASE 18 MG, 27 MG, 54 MG
QL Criteria 2 tablets Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
111
![Page 112: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/112.jpg)
Concerta
Products Affected• CONCERTA ORAL TABLET EXTENDED
RELEASE 36 MG
QL Criteria 4 tablets Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
112
![Page 113: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/113.jpg)
ConZip
Products Affected• CONZIP
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
113
![Page 114: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/114.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
114
![Page 115: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/115.jpg)
Copaxone
Products Affected• COPAXONE SUBCUTANEOUS
SOLUTION PREFILLED SYRINGE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/glatiramer.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
115
![Page 116: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/116.jpg)
Corifact
Products Affected• CORIFACT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
116
![Page 117: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/117.jpg)
Cosentyx
Products Affected• COSENTYX
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Cosentyx.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
117
![Page 118: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/118.jpg)
Cosentyx Sensoready Pen
Products Affected• COSENTYX SENSOREADY PEN
SUBCUTANEOUS SOLUTION AUTO-INJECTOR 150 MG/ML
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Cosentyx.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
118
![Page 119: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/119.jpg)
Cotellic
Products Affected• COTELLIC
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
119
![Page 120: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/120.jpg)
Cotempla XR-ODT
Products Affected• COTEMPLA XR-ODT
QL Criteria 1 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
120
![Page 121: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/121.jpg)
Cuprimine
Products Affected• CUPRIMINE ORAL CAPSULE 250 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/metabolic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
121
![Page 122: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/122.jpg)
Cuvitru
Products Affected• CUVITRU
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/ivig.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
122
![Page 123: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/123.jpg)
Cystadane
Products Affected• CYSTADANE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/metabolic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
123
![Page 124: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/124.jpg)
Cystaran
Products Affected• CYSTARAN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/EYE/ophthalmic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
124
![Page 125: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/125.jpg)
Daklinza
Products Affected• DAKLINZA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
125
![Page 126: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/126.jpg)
Daytrana
Products Affected• DAYTRANA
QL Criteria 1 patch Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
126
![Page 127: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/127.jpg)
Demerol
Products Affected• DEMEROL ORAL
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
127
![Page 128: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/128.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
128
![Page 129: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/129.jpg)
Depen Titratabs
Products Affected• DEPEN TITRATABS
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/metabolic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
129
![Page 130: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/130.jpg)
Descovy
Products Affected• DESCOVY
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ID/antiviral_hiv.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
130
![Page 131: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/131.jpg)
Desoxyn
Products Affected• DESOXYN
QL Criteria 4 tablets Per 1 Day
Notes/References
Annual Review: 10/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
131
![Page 132: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/132.jpg)
Dexedrine
Products Affected• DEXEDRINE ORAL CAPSULE
EXTENDED RELEASE 24 HOUR
QL Criteria 3 capsules Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
132
![Page 133: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/133.jpg)
Dexedrine
Products Affected• DEXEDRINE ORAL TABLET
QL Criteria 4 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
133
![Page 134: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/134.jpg)
Dexmethylphenidate HCl
Products Affected• dexmethylphenidate hcl
QL Criteria 4 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
134
![Page 135: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/135.jpg)
Dexmethylphenidate HCl ER
Products Affected• dexmethylphenidate hcl er oral capsule
extended release 24 hour 10 mg, 20 mg, 30 mg
• dexmethylphenidate hcl er oral capsule extended release 24 hour 15 mg, 40 mg, 5 mg
QL Criteria 2 capsules Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
135
![Page 136: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/136.jpg)
Dextroamphetamine Sulfate
Products Affected• dextroamphetamine sulfate oral solution
QL Criteria 40 ML Per 1 Day
Notes/References
Annual Review: 10/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
136
![Page 137: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/137.jpg)
Dextroamphetamine Sulfate
Products Affected• dextroamphetamine sulfate oral tablet
QL Criteria 4 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
137
![Page 138: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/138.jpg)
Dextroamphetamine Sulfate ER
Products Affected• dextroamphetamine sulfate er
QL Criteria 3 capsules Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
138
![Page 139: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/139.jpg)
Dibenzyline
Products Affected• DIBENZYLINE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/antihypertensive_misc.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
139
![Page 140: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/140.jpg)
Diclofenac Sodium
Products Affected• diclofenac sodium transdermal gel 1 %
QL Criteria 200 grams Per 30 Days
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
140
![Page 141: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/141.jpg)
Diclofenac Sodium
Products Affected• diclofenac sodium transdermal gel 3 %
PA Criteria Criteria Details
Covered Uses Actinic keratoses (AK)
Exclusion Criteria
Documentation of any of the following patients/situations: use in treatment of postoperative pain after coronary artery bypass graft (CABG) surgery, any known hypersensitivity to diclofenac or any component of the formulation, any history of Asthma and aspirin triad, the planned area of application includes non-intact skin, or if the medication will be compounded with other products that would alter the total dose/dosage form being administered
Required Medical Information
Documentation that sun avoidance is indicated during therapy
Age Restrictions
Prescriber Restrictions
Coverage Duration
1 year
Other Criteria
QL Criteria 100 grams Per 30 Days
Notes/References
Revision DatePrior Authorization: September 29, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
141
![Page 142: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/142.jpg)
Dilaudid
Products Affected• DILAUDID ORAL
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
142
![Page 143: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/143.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
143
![Page 144: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/144.jpg)
Dolophine
Products Affected• DOLOPHINE
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
144
![Page 145: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/145.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
145
![Page 146: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/146.jpg)
Doxepin HCl
Products Affected• doxepin hcl external
QL Criteria 45 grams Per 30 Days
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
146
![Page 147: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/147.jpg)
Dupixent
Products Affected• DUPIXENT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Dupixent.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
147
![Page 148: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/148.jpg)
Duragesic-100
Products Affected• DURAGESIC-100
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
148
![Page 149: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/149.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
149
![Page 150: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/150.jpg)
Duragesic-12
Products Affected• DURAGESIC-12
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
150
![Page 151: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/151.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
151
![Page 152: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/152.jpg)
Duragesic-25
Products Affected• DURAGESIC-25
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
152
![Page 153: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/153.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
153
![Page 154: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/154.jpg)
Duragesic-50
Products Affected• DURAGESIC-50
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
154
![Page 155: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/155.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
155
![Page 156: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/156.jpg)
Duragesic-75
Products Affected• DURAGESIC-75
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
156
![Page 157: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/157.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
157
![Page 158: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/158.jpg)
Dyanavel XR
Products Affected• DYANAVEL XR
QL Criteria 240 ml Per 30 Days
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
158
![Page 159: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/159.jpg)
Dysport
Products Affected• DYSPORT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/botulinum_toxin.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
159
![Page 160: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/160.jpg)
Elaprase
Products Affected• ELAPRASE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/lysosomal_storage.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
160
![Page 161: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/161.jpg)
Elelyso
Products Affected• ELELYSO
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/gaucher_disease.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
161
![Page 162: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/162.jpg)
Eligard
Products Affected• ELIGARD
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Gonadotropins.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
162
![Page 163: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/163.jpg)
Ella
Products Affected• ELLA
QL Criteria 2 tablets Per 1 fill
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
163
![Page 164: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/164.jpg)
Eloctate
Products Affected• ELOCTATE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
164
![Page 165: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/165.jpg)
Embeda
Products Affected• EMBEDA
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
165
![Page 166: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/166.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Annual Review: 06/2017
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
166
![Page 167: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/167.jpg)
Emflaza
Products Affected• EMFLAZA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Emflaza.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
167
![Page 168: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/168.jpg)
EMLA
Products Affected• EMLA
PA Criteria Criteria Details
Covered Uses
***AUTHORIZATION IS NOT REQUIRED FOR LESS THAN 50 GRAMS OF LIDOCAINE EVERY 30 DAYS*** For quantities over 50 grams every 30 days, there must be a documented temporary need for topical anesthetic in either of the following situations: Normal, intact skin for local analgesia, or Genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia
Exclusion Criteria
Documentation of any of the following: Planned area of application includes non-intact skin, Sensitivity to amide-type local anesthetics or any other component of the product, Planned use on large surface area of the body or for a period of time over 3 hours as this can lead to increased toxicity, the medication is being used in conjunction with a cosmetic procedure (i.e. hair removal), Use in situations where the drug may migrate into the middle ear, beyond the tympanic membrane, History of methemoglobinemia, or if the product will be compounded with other products that would alter the total dose/dosage form being administered
Required Medical Information
A documented need for topical anesthetic in either of the following situations: Normal, intact skin for local analgesia, or Genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia
Age Restrictions
Prescriber Restrictions
Coverage Duration
3 months
2018 Aetna Premier Plus Plan01/01/2018
168
![Page 169: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/169.jpg)
PA Criteria Criteria Details
Other Criteria
*Topical lidocaine/prilocaine cream is used for temporary anesthesia. Prescription renewals for longer than 3 months require clinical documentation of medical necessity.Due to Safety Concerns higher quantities and prolonged use are not recommended. Renewal Duration: 3 months *Up to an additional 30 grams per 30 days. Higher additional quantities are not approvable.
Notes/References
Revision DatePrior Authorization: October 03, 2016Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
169
![Page 170: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/170.jpg)
Enbrel
Products Affected• ENBREL SUBCUTANEOUS KIT• ENBREL SUBCUTANEOUS SOLUTION
PREFILLED SYRINGE 25 MG/0.5ML
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Enbrel.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 8 units Per 28 Days
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
170
![Page 171: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/171.jpg)
Enbrel
Products Affected• ENBREL SUBCUTANEOUS SOLUTION
PREFILLED SYRINGE 50 MG/ML
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Enbrel.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 4 units Per 28 Days
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
171
![Page 172: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/172.jpg)
Enbrel SureClick
Products Affected• ENBREL SURECLICK SUBCUTANEOUS
SOLUTION AUTO-INJECTOR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Enbrel.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 4 units Per 28 Days
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
172
![Page 173: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/173.jpg)
Endocet
Products Affected• ENDOCET ORAL TABLET 10-325 MG,
2.5-325 MG, 5-325 MG, 7.5-325 MG
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
173
![Page 174: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/174.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
174
![Page 175: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/175.jpg)
Entecavir
Products Affected• entecavir
QL Criteria 1 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
175
![Page 176: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/176.jpg)
Entyvio
Products Affected• ENTYVIO
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Entyvio.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
176
![Page 177: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/177.jpg)
Epclusa
Products Affected• EPCLUSA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
177
![Page 178: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/178.jpg)
Epogen
Products Affected• EPOGEN INJECTION SOLUTION 10000
UNIT/ML, 2000 UNIT/ML, 20000 UNIT/ML, 3000 UNIT/ML, 4000 UNIT/ML
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Erythropoiesis_Stimulating_Agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
178
![Page 179: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/179.jpg)
Epoprostenol Sodium
Products Affected• epoprostenol sodium
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
179
![Page 180: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/180.jpg)
Erivedge
Products Affected• ERIVEDGE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 1 capsule Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
180
![Page 181: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/181.jpg)
Esbriet
Products Affected• ESBRIET ORAL CAPSULE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Idiopathic_Pulmonary_Fibrosis.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 9 capsules Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
181
![Page 182: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/182.jpg)
Esbriet
Products Affected• ESBRIET ORAL TABLET
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Idiopathic_Pulmonary_Fibrosis.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
182
![Page 183: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/183.jpg)
Euflexxa
Products Affected• EUFLEXXA INTRA-ARTICULAR
SOLUTION PREFILLED SYRINGE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/viscosupplements.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
183
![Page 184: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/184.jpg)
Evekeo
Products Affected• EVEKEO
QL Criteria 120 tablets Per 30 Days
Notes/References
Annual Review: 02/2017
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
184
![Page 185: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/185.jpg)
Exalgo
Products Affected• EXALGO ORAL TABLET ER 24 HOUR
ABUSE-DETERRENT
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
185
![Page 186: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/186.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
186
![Page 187: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/187.jpg)
Exjade
Products Affected• EXJADE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Anitdotes.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
187
![Page 188: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/188.jpg)
Extavia
Products Affected• EXTAVIA SUBCUTANEOUS KIT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/MSinterferons.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 15 vials Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
188
![Page 189: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/189.jpg)
Eylea
Products Affected• EYLEA INTRAOCULAR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/EYE/ophthalmic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
189
![Page 190: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/190.jpg)
Fabrazyme
Products Affected• FABRAZYME
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/lysosomal_storage.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
190
![Page 191: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/191.jpg)
Falmina
Products Affected• FALMINA
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
191
![Page 192: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/192.jpg)
Farydak
Products Affected• FARYDAK
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 12 capsules Per 30 Days
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
192
![Page 193: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/193.jpg)
Faslodex
Products Affected• FASLODEX INTRAMUSCULAR
SOLUTION 250 MG/5ML
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
193
![Page 194: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/194.jpg)
Feiba
Products Affected• FEIBA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
194
![Page 195: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/195.jpg)
Feiba NF
Products Affected• FEIBA NF
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
195
![Page 196: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/196.jpg)
Feiba VH Immuno
Products Affected• FEIBA VH IMMUNO
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
196
![Page 197: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/197.jpg)
FentaNYL
Products Affected• fentanyl
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
197
![Page 198: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/198.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
198
![Page 199: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/199.jpg)
FentaNYL Citrate
Products Affected• fentanyl citrate buccal
PA Criteria Criteria Details
Covered Uses Breakthrough cancer pain, General anesthesia
Exclusion Criteria
Required Medical Information
A documented diagnosis of cancer and concomitant use of long acting opioid therapy or member's resident state or contract state is California and the member is terminally ill
Age Restrictions
Prescriber Restrictions
Coverage Duration
1 year
2018 Aetna Premier Plus Plan01/01/2018
199
![Page 200: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/200.jpg)
PA Criteria Criteria Details
Other Criteria
For coverage of additional quantities, member must meet the following requirements: A Documented diagnosis of cancer and prescription is written by an oncologist or pain specialist, or member is enrolled in a hospice program or meets hospice criteria, or member's resident state or contract state is California and the member is terminally ill, or the patient has signed opioid agreement in support of clinical guidelines by the American Pain Society and the American Academy of Pain Medicine, Healthcare Provider verbal confirmation that an agreement has been signed by the patient meets the criteria requirement.*Exceptions to requiring the signed opioid agreement for additional quantities are only for those patients that have a diagnosis of cancer or that are enrolled in a hospice program and documentation of one of the following: Member has current diagnosis of cancer(*see exception to opioid agreement above) as the primary cause of the pain and is currently on long-acting opioid and is being titrated on the long-acting opioid by physician, and member has tried and failed an adequate trial of two weeks of a single entity or combination pain medication containing an immediate release acting opioid (ex. oxycodone, morphine sulfate oral(Roxanol), oxymorphone(Opana), hydromorphone(Dilaudid), oxycodone/apap(Percocet))
QL Criteria 120 lozenges Per 30 Days
Notes/References
Annual Review: 06/2017
Revision DatePrior Authorization: April 25, 2016Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
200
![Page 201: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/201.jpg)
Fentora
Products Affected• FENTORA BUCCAL TABLET 100 MCG,
200 MCG, 400 MCG, 600 MCG, 800 MCG
PA Criteria Criteria Details
Covered Uses Breakthrough cancer pain, General anesthesia
Exclusion Criteria
Required Medical Information
A documented diagnosis of cancer and concomitant use of long acting opioid therapy or member's resident state or contract state is California and the member is terminally ill
Age Restrictions
Prescriber Restrictions
Coverage Duration
1 year
2018 Aetna Premier Plus Plan01/01/2018
201
![Page 202: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/202.jpg)
PA Criteria Criteria Details
Other Criteria
For coverage of additional quantities, member must meet the following requirements: A Documented diagnosis of cancer and prescription is written by an oncologist or pain specialist, or member is enrolled in a hospice program or meets hospice criteria, or member's resident state or contract state is California and the member is terminally ill, or the patient has signed opioid agreement in support of clinical guidelines by the American Pain Society and the American Academy of Pain Medicine, Healthcare Provider verbal confirmation that an agreement has been signed by the patient meets the criteria requirement.*Exceptions to requiring the signed opioid agreement for additional quantities are only for those patients that have a diagnosis of cancer or that are enrolled in a hospice program and documentation of one of the following: Member has current diagnosis of cancer(*see exception to opioid agreement above) as the primary cause of the pain and is currently on long-acting opioid and is being titrated on the long-acting opioid by physician, and member has tried and failed an adequate trial of two weeks of a single entity or combination pain medication containing an immediate release acting opioid (ex. oxycodone, morphine sulfate oral(Roxanol), oxymorphone(Opana), hydromorphone(Dilaudid), oxycodone/apap(Percocet))
QL Criteria 120 tablets Per 30 Days
Notes/References
Annual Review: 06/2017
Revision DatePrior Authorization: April 25, 2016Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
202
![Page 203: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/203.jpg)
Ferriprox
Products Affected• FERRIPROX
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Anitdotes.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
203
![Page 204: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/204.jpg)
Fioricet/Codeine
Products Affected• FIORICET/CODEINE ORAL CAPSULE
50-300-40-30 MG
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
204
![Page 205: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/205.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
205
![Page 206: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/206.jpg)
Fiorinal/Codeine #3
Products Affected• FIORINAL/CODEINE #3
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
206
![Page 207: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/207.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
207
![Page 208: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/208.jpg)
Firazyr
Products Affected• FIRAZYR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/hereditary_angioedema.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
208
![Page 209: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/209.jpg)
Firmagon
Products Affected• FIRMAGON
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Gonadotropins.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
209
![Page 210: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/210.jpg)
Flebogamma
Products Affected• FLEBOGAMMA INTRAVENOUS
SOLUTION 0.5 GM/10ML
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/ivig.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
210
![Page 211: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/211.jpg)
Flebogamma DIF
Products Affected• FLEBOGAMMA DIF
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/ivig.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
211
![Page 212: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/212.jpg)
Flolan
Products Affected• FLOLAN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
212
![Page 213: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/213.jpg)
Focalin
Products Affected• FOCALIN
QL Criteria 4 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
213
![Page 214: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/214.jpg)
Focalin XR
Products Affected• FOCALIN XR
QL Criteria 2 capsules Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
214
![Page 215: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/215.jpg)
Follistim AQ
Products Affected• FOLLISTIM AQ
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/infertility.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
215
![Page 216: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/216.jpg)
Fuzeon
Products Affected• FUZEON
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ID/antiviral_hiv.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
216
![Page 217: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/217.jpg)
Gammagard
Products Affected• GAMMAGARD
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/ivig.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
217
![Page 218: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/218.jpg)
Gammagard S/D
Products Affected• GAMMAGARD S/D INTRAVENOUS
SOLUTION RECONSTITUTED 10 GM, 5 GM
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/ivig.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
218
![Page 219: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/219.jpg)
Gammaked
Products Affected• GAMMAKED
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/ivig.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
219
![Page 220: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/220.jpg)
Gammaplex
Products Affected• GAMMAPLEX INTRAVENOUS
SOLUTION 10 GM/200ML, 2.5 GM/50ML, 20 GM/400ML, 5 GM/100ML
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/ivig.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
220
![Page 221: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/221.jpg)
Gamunex-C
Products Affected• GAMUNEX-C
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/ivig.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
221
![Page 222: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/222.jpg)
Ganirelix Acetate
Products Affected• ganirelix acetate
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/infertility.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
222
![Page 223: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/223.jpg)
Gattex
Products Affected• GATTEX
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Gattex.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
223
![Page 224: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/224.jpg)
Gel-One
Products Affected• GEL-ONE INTRA-ARTICULAR
PREFILLED SYRINGE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/viscosupplements.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
224
![Page 225: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/225.jpg)
Gelsyn-3
Products Affected• GELSYN-3
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/viscosupplements.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
225
![Page 226: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/226.jpg)
Genotropin
Products Affected• GENOTROPIN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
226
![Page 227: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/227.jpg)
Genotropin MiniQuick
Products Affected• GENOTROPIN MINIQUICK
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
227
![Page 228: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/228.jpg)
Gildagia
Products Affected• GILDAGIA
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
228
![Page 229: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/229.jpg)
Gildess FE 1.5/30
Products Affected• GILDESS FE 1.5/30
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
229
![Page 230: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/230.jpg)
Gildess FE 1/20
Products Affected• GILDESS FE 1/20
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
230
![Page 231: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/231.jpg)
Gilenya
Products Affected• GILENYA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/Gilenya.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 1 capsule Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
231
![Page 232: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/232.jpg)
Gilotrif
Products Affected• GILOTRIF
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
232
![Page 233: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/233.jpg)
Glassia
Products Affected• GLASSIA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/Alpha-1 Antitrypsin Inhibitor Therapy.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
233
![Page 234: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/234.jpg)
Glatopa
Products Affected• GLATOPA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/glatiramer.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
234
![Page 235: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/235.jpg)
Gleevec
Products Affected• GLEEVEC
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
235
![Page 236: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/236.jpg)
Gonal-f
Products Affected• GONAL-F
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/infertility.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
236
![Page 237: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/237.jpg)
Gonal-f RFF
Products Affected• GONAL-F RFF
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/infertility.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
237
![Page 238: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/238.jpg)
Gonal-f RFF Pen
Products Affected• GONAL-F RFF PEN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/infertility.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
238
![Page 239: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/239.jpg)
Gonal-f RFF Rediject
Products Affected• GONAL-F RFF REDIJECT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/infertility.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
239
![Page 240: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/240.jpg)
Granix
Products Affected• GRANIX
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/G-CSF.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
240
![Page 241: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/241.jpg)
GuanFACINE HCl ER
Products Affected• guanfacine hcl er
QL Criteria 1 tablet Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
241
![Page 242: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/242.jpg)
Haegarda
Products Affected• HAEGARDA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/hereditary_angioedema.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
242
![Page 243: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/243.jpg)
Harvoni
Products Affected• HARVONI
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 1 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
243
![Page 244: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/244.jpg)
Helixate FS
Products Affected• HELIXATE FS
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
244
![Page 245: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/245.jpg)
Hemofil M
Products Affected• HEMOFIL M INTRAVENOUS SOLUTION
RECONSTITUTED 1000 UNIT, 1501-2000 UNIT, 1700 UNIT, 220-400 UNIT, 250 UNIT, 401-800 UNIT, 500 UNIT, 801-1500 UNIT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
245
![Page 246: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/246.jpg)
Hetlioz
Products Affected• HETLIOZ
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/sedative-hypnotics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
246
![Page 247: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/247.jpg)
Hizentra
Products Affected• HIZENTRA SUBCUTANEOUS
SOLUTION 1 GM/5ML, 10 GM/50ML, 2 GM/10ML, 4 GM/20ML
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/ivig.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
247
![Page 248: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/248.jpg)
HP Acthar
Products Affected• HP ACTHAR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/acthar.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
248
![Page 249: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/249.jpg)
Humate-P
Products Affected• HUMATE-P INTRAVENOUS SOLUTION
RECONSTITUTED 1000-2400 UNIT, 250-600 UNIT, 500-1200 UNIT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
249
![Page 250: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/250.jpg)
Humatrope
Products Affected• HUMATROPE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
250
![Page 251: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/251.jpg)
Humira
Products Affected• HUMIRA SUBCUTANEOUS PREFILLED
SYRINGE KIT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Humira.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
251
![Page 252: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/252.jpg)
Humira Pediatric Crohns Start
Products Affected• HUMIRA PEDIATRIC CROHNS START
SUBCUTANEOUS PREFILLED SYRINGE KIT 40 MG/0.8ML
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Humira.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
252
![Page 253: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/253.jpg)
Humira Pen
Products Affected• HUMIRA PEN SUBCUTANEOUS PEN-
INJECTOR KIT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Humira.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
253
![Page 254: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/254.jpg)
Humira Pen-Crohns Starter
Products Affected• HUMIRA PEN-CROHNS STARTER
SUBCUTANEOUS PEN-INJECTOR KIT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Humira.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
254
![Page 255: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/255.jpg)
Humira Pen-Psoriasis Starter
Products Affected• HUMIRA PEN-PSORIASIS STARTER
SUBCUTANEOUS PEN-INJECTOR KIT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Humira.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
255
![Page 256: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/256.jpg)
Hyalgan
Products Affected• HYALGAN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/viscosupplements.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
256
![Page 257: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/257.jpg)
Hycamtin
Products Affected• HYCAMTIN ORAL
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
257
![Page 258: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/258.jpg)
Hycet
Products Affected• HYCET
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
258
![Page 259: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/259.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
259
![Page 260: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/260.jpg)
Hydrocodone-Acetaminophen
Products Affected• hydrocodone-acetaminophen oral solution
10-325 mg/15ml, 2.5-108 mg/5ml, 5-217 mg/10ml, 7.5-325 mg/15ml
• hydrocodone-acetaminophen oral tablet 10-300 mg, 10-325 mg, 2.5-325 mg, 5-300 mg, 5-325 mg, 7.5-300 mg, 7.5-325 mg
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
260
![Page 261: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/261.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
261
![Page 262: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/262.jpg)
Hydrocodone-Ibuprofen
Products Affected• hydrocodone-ibuprofen
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
262
![Page 263: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/263.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
263
![Page 264: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/264.jpg)
HYDROmorphone HCl
Products Affected• hydromorphone hcl oral • hydromorphone hcl rectal
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
264
![Page 265: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/265.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
265
![Page 266: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/266.jpg)
HYDROmorphone HCl ER
Products Affected• hydromorphone hcl er
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
266
![Page 267: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/267.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
267
![Page 268: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/268.jpg)
Hymovis
Products Affected• HYMOVIS
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/viscosupplements.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
268
![Page 269: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/269.jpg)
Hyqvia
Products Affected• HYQVIA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/ivig.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
269
![Page 270: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/270.jpg)
Hysingla ER
Products Affected• HYSINGLA ER
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
270
![Page 271: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/271.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
271
![Page 272: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/272.jpg)
Ibrance
Products Affected• IBRANCE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 21 capsules Per 28 Days
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
272
![Page 273: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/273.jpg)
Ibudone
Products Affected• IBUDONE
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
273
![Page 274: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/274.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
274
![Page 275: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/275.jpg)
Iclusig
Products Affected• ICLUSIG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
275
![Page 276: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/276.jpg)
Idelvion
Products Affected• IDELVION
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
276
![Page 277: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/277.jpg)
IDHIFA
Products Affected• IDHIFA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Idhifa.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
277
![Page 278: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/278.jpg)
Ilaris
Products Affected• ILARIS
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Ilaris.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
278
![Page 279: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/279.jpg)
Ilaris (150mg Delivered)
Products Affected• ILARIS (150MG DELIVERED)
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Ilaris.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
279
![Page 280: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/280.jpg)
Imatinib Mesylate
Products Affected• imatinib mesylate
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
280
![Page 281: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/281.jpg)
Imbruvica
Products Affected• IMBRUVICA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
281
![Page 282: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/282.jpg)
Increlex
Products Affected• INCRELEX
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/Increlex.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
282
![Page 283: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/283.jpg)
Infergen
Products Affected• INFERGEN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
283
![Page 284: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/284.jpg)
Inflectra
Products Affected• INFLECTRA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Inflectra.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
284
![Page 285: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/285.jpg)
Ingrezza
Products Affected• INGREZZA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/Ingrezza.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
285
![Page 286: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/286.jpg)
Inlyta
Products Affected• INLYTA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
286
![Page 287: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/287.jpg)
Intron A
Products Affected• INTRON A
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
287
![Page 288: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/288.jpg)
Intuniv
Products Affected• INTUNIV
QL Criteria 1 tablet Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
288
![Page 289: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/289.jpg)
Iressa
Products Affected• IRESSA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Iressa.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
289
![Page 290: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/290.jpg)
Ixinity
Products Affected• IXINITY
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
290
![Page 291: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/291.jpg)
Jadenu
Products Affected• JADENU
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Anitdotes.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
291
![Page 292: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/292.jpg)
Jadenu Sprinkle
Products Affected• JADENU SPRINKLE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Anitdotes.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
292
![Page 293: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/293.jpg)
Jakafi
Products Affected• JAKAFI
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 2 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
293
![Page 294: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/294.jpg)
Jetrea
Products Affected• JETREA INTRAOCULAR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/EYE/ophthalmic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
294
![Page 295: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/295.jpg)
Junel 1.5/30
Products Affected• JUNEL 1.5/30
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
295
![Page 296: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/296.jpg)
Junel 1/20
Products Affected• JUNEL 1/20
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
296
![Page 297: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/297.jpg)
Junel FE 1.5/30
Products Affected• JUNEL FE 1.5/30
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
297
![Page 298: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/298.jpg)
Junel FE 1/20
Products Affected• JUNEL FE 1/20
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
298
![Page 299: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/299.jpg)
Juxtapid
Products Affected• JUXTAPID ORAL CAPSULE 10 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/Antilipidemic Agents_HOFH.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 28 capsules Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
299
![Page 300: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/300.jpg)
Juxtapid
Products Affected• JUXTAPID ORAL CAPSULE 20 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/Antilipidemic Agents_HOFH.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 84 capsules Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
300
![Page 301: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/301.jpg)
Juxtapid
Products Affected• JUXTAPID ORAL CAPSULE 30 MG, 40
MG, 60 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/Antilipidemic Agents_HOFH.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
301
![Page 302: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/302.jpg)
Juxtapid
Products Affected• JUXTAPID ORAL CAPSULE 5 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/Antilipidemic Agents_HOFH.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 14 capsules Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
302
![Page 303: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/303.jpg)
Kadian
Products Affected• KADIAN ORAL CAPSULE EXTENDED
RELEASE 24 HOUR 10 MG, 100 MG, 20 MG, 30 MG, 50 MG, 60 MG, 80 MG
• KADIAN ORAL CAPSULE EXTENDED RELEASE 24 HOUR 200 MG, 40 MG, 70 MG
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
303
![Page 304: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/304.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
304
![Page 305: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/305.jpg)
Kalbitor
Products Affected• KALBITOR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/hereditary_angioedema.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
305
![Page 306: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/306.jpg)
Kalydeco
Products Affected• KALYDECO ORAL PACKET
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/cystic_fibrosis.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
306
![Page 307: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/307.jpg)
Kalydeco
Products Affected• KALYDECO ORAL TABLET
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/cystic_fibrosis.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 2 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
307
![Page 308: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/308.jpg)
Kanuma
Products Affected• KANUMA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/lysosomal_storage.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
308
![Page 309: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/309.jpg)
Kapvay
Products Affected• KAPVAY ORAL
QL Criteria 2 EA Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
309
![Page 310: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/310.jpg)
Kapvay
Products Affected• KAPVAY ORAL TABLET EXTENDED
RELEASE 12 HOUR
QL Criteria 4 tablets Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
310
![Page 311: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/311.jpg)
Kariva
Products Affected• KARIVA
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
311
![Page 312: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/312.jpg)
Kelnor 1/35
Products Affected• KELNOR 1/35
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
312
![Page 313: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/313.jpg)
Keveyis
Products Affected• KEVEYIS
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/carbonic_anhydrase_inhibitor.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
313
![Page 314: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/314.jpg)
Kevzara
Products Affected• KEVZARA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Kevzara.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
314
![Page 315: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/315.jpg)
Kineret
Products Affected• KINERET SUBCUTANEOUS SOLUTION
PREFILLED SYRINGE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Kineret.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
315
![Page 316: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/316.jpg)
Kisqali 200 Dose
Products Affected• KISQALI 200 DOSE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Kisqali.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
316
![Page 317: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/317.jpg)
Kisqali 400 Dose
Products Affected• KISQALI 400 DOSE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Kisqali.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
317
![Page 318: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/318.jpg)
Kisqali 600 Dose
Products Affected• KISQALI 600 DOSE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Kisqali.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
318
![Page 319: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/319.jpg)
Kisqali Femara 200 Dose
Products Affected• KISQALI FEMARA 200 DOSE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Kisqali.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
319
![Page 320: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/320.jpg)
Kisqali Femara 400 Dose
Products Affected• KISQALI FEMARA 400 DOSE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Kisqali.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
320
![Page 321: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/321.jpg)
Kisqali Femara 600 Dose
Products Affected• KISQALI FEMARA 600 DOSE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Kisqali.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
321
![Page 322: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/322.jpg)
Koate
Products Affected• KOATE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
322
![Page 323: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/323.jpg)
Koate-DVI
Products Affected• KOATE-DVI
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
323
![Page 324: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/324.jpg)
Kogenate FS
Products Affected• KOGENATE FS
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
324
![Page 325: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/325.jpg)
Kogenate FS Bio-Set
Products Affected• KOGENATE FS BIO-SET
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
325
![Page 326: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/326.jpg)
Korlym
Products Affected• KORLYM
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/antidiabetic agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 4 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
326
![Page 327: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/327.jpg)
Kovaltry
Products Affected• KOVALTRY
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
327
![Page 328: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/328.jpg)
Krystexxa
Products Affected• KRYSTEXXA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/gout.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
328
![Page 329: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/329.jpg)
Kurvelo
Products Affected• KURVELO
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
329
![Page 330: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/330.jpg)
Kuvan
Products Affected• KUVAN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/metabolic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
330
![Page 331: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/331.jpg)
Kynamro
Products Affected• KYNAMRO SUBCUTANEOUS
SOLUTION PREFILLED SYRINGE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/Antilipidemic Agents_HOFH.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
331
![Page 332: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/332.jpg)
Lazanda
Products Affected• LAZANDA
PA Criteria Criteria Details
Covered Uses Breakthrough cancer pain, General anesthesia
Exclusion Criteria
Required Medical Information
A documented diagnosis of cancer and concomitant use of long acting opioid therapy or member's resident state or contract state is California and the member is terminally ill
Age Restrictions
Prescriber Restrictions
Coverage Duration
1 year
2018 Aetna Premier Plus Plan01/01/2018
332
![Page 333: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/333.jpg)
PA Criteria Criteria Details
Other Criteria
For coverage of additional quantities, member must meet the following requirements: A Documented diagnosis of cancer and prescription is written by an oncologist or pain specialist, or member is enrolled in a hospice program or meets hospice criteria, or member's resident state or contract state is California and the member is terminally ill, or the patient has signed opioid agreement in support of clinical guidelines by the American Pain Society and the American Academy of Pain Medicine, Healthcare Provider verbal confirmation that an agreement has been signed by the patient meets the criteria requirement.*Exceptions to requiring the signed opioid agreement for additional quantities are only for those patients that have a diagnosis of cancer or that are enrolled in a hospice program and documentation of one of the following: Member has current diagnosis of cancer(*see exception to opioid agreement above) as the primary cause of the pain and is currently on long-acting opioid and is being titrated on the long-acting opioid by physician, and member has tried and failed an adequate trial of two weeks of a single entity or combination pain medication containing an immediate release acting opioid (ex. oxycodone, morphine sulfate oral(Roxanol), oxymorphone(Opana), hydromorphone(Dilaudid), oxycodone/apap(Percocet))
QL Criteria 4 bottles Per 30 Days
Notes/References
Annual Review: 06/2017
Revision DatePrior Authorization: April 25, 2016Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
333
![Page 334: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/334.jpg)
Lazanda
Products Affected• LAZANDA
PA Criteria Criteria Details
Covered Uses Breakthrough cancer pain, General anesthesia
Exclusion Criteria
Required Medical Information
Documentation that member is terminally ill or has a documented diagnosis of cancer with concomitant use of around the clock long acting opioid therapy for cancer pain, requiring management of breakthrough pain and is intolerant of two (2) immediate-release opioids including morphine, hydrocodone, oxycodone, or hydromorphone.
Age Restrictions
Prescriber Restrictions
Coverage Duration
1 year
Other Criteria Step therapy may apply
QL Criteria 4 bottles Per 30 Days
Notes/References
Annual Review: 06/2017
Revision DatePrior Authorization: December 29, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
334
![Page 335: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/335.jpg)
Leena
Products Affected• LEENA
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
335
![Page 336: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/336.jpg)
Lemtrada
Products Affected• LEMTRADA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/Lemtrada.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 5 vials Per 365 Days
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
336
![Page 337: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/337.jpg)
Lenvima 10 MG Daily Dose
Products Affected• LENVIMA 10 MG DAILY DOSE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 day supply Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
337
![Page 338: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/338.jpg)
Lenvima 14 MG Daily Dose
Products Affected• LENVIMA 14 MG DAILY DOSE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 day supply Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
338
![Page 339: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/339.jpg)
Lenvima 18 MG Daily Dose
Products Affected• LENVIMA 18 MG DAILY DOSE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
339
![Page 340: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/340.jpg)
Lenvima 20 MG Daily Dose
Products Affected• LENVIMA 20 MG DAILY DOSE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 day supply Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
340
![Page 341: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/341.jpg)
Lenvima 24 MG Daily Dose
Products Affected• LENVIMA 24 MG DAILY DOSE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 day supply Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
341
![Page 342: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/342.jpg)
Lenvima 8 MG Daily Dose
Products Affected• LENVIMA 8 MG DAILY DOSE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
342
![Page 343: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/343.jpg)
Lessina
Products Affected• LESSINA
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
343
![Page 344: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/344.jpg)
Letairis
Products Affected• LETAIRIS
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
344
![Page 345: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/345.jpg)
Leukine
Products Affected• LEUKINE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/G-CSF.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
345
![Page 346: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/346.jpg)
Leuprolide Acetate
Products Affected• leuprolide acetate injection
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Gonadotropins.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
346
![Page 347: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/347.jpg)
Levonest
Products Affected• LEVONEST
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
347
![Page 348: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/348.jpg)
Levonorgestrel-Ethinyl Estrad
Products Affected• levonorgestrel-ethinyl estrad oral tablet
0.15-30 mg-mcg
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
348
![Page 349: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/349.jpg)
Levora 0.15/30 (28)
Products Affected• LEVORA 0.15/30 (28)
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
349
![Page 350: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/350.jpg)
Levorphanol Tartrate
Products Affected• levorphanol tartrate oral
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
350
![Page 351: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/351.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
351
![Page 352: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/352.jpg)
Lidocaine
Products Affected• lidocaine external ointment
PA Criteria Criteria Details
Covered Uses
***AUTHORIZATION IS NOT REQUIRED FOR LESS THAN 50 GRAMS OF LIDOCAINE EVERY 30 DAYS*** For quantities over 50 grams every 30 days, there must be a documented temporary need for anesthesia for any of the following: Accessible mucous membranes of the oropharynx, skin and mucous membranes or stomatitis, or pain associated with a minor burns, including sunburn, abrasions of the skin, and insect bites.
Exclusion Criteria
Documentation of any of the following: Planned area of application includes non-intact skin, sensitivity to amide-type local anesthetics or any other component of the product, planned use on large surface area of the body as this can lead to increased toxicity, planned area of application includes severely traumatized skin (e.g.,mucosal or skin abrasion, eczema, burns), the medication is being used in conjunction with a cosmetic procedure (i.e. hair removal), of if the product will be compounded with other products that would alter the total dose/dosage form being administered
Required Medical Information
A documented need for temporary anesthesia for any of the following: Accessible mucous membranes of the oropharynx, skin and mucous membranes or stomatitis, or pain associated with a minor burns, including sunburn, abrasions of the skin, and insect bites.
Age Restrictions
Prescriber Restrictions
Coverage Duration
3 months
2018 Aetna Premier Plus Plan01/01/2018
352
![Page 353: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/353.jpg)
PA Criteria Criteria Details
Other Criteria
*Topical lidocaine ointment is used for temporary anesthesia. Prescription renewals for longer than 3 months require clinical documentation of medical necessity. Due to Safety Concerns higher quantities and prolonged use are not recommended. Renewal Duration: 3 months *Approval can made up to an additional 50gms per 30 days. Higher additional quantities are not approvable *FOR ADULTS: A single application should not exceed 5 g of Lidocaine Ointment 5%, containing 250 mg of lidocaine base (equivalent chemically to approximately 300 mg of lidocaine hydrochloride). This is roughly equivalent to squeezing a six (6) inch length of ointment from the tube. In a 70 kg adult this dose equals 3.6 mg/kg (1.6 mg/lb) lidocaine base. No more than one-half tube, approximately 17-20 g of ointment or 850-1000 mg lidocaine base, should be administered in any one day. FOR CHILDREN: For children less than ten years who have a normal lean body mass and a normal lean body development, the maximum dose may be determined by the application of one of the standard pediatric drug formulas (e.g., Clark's rule). For example a child of five years weighing 50 lbs., the dose of lidocaine should not exceed 75-100 mg when calculated according to Clark's rule. In any case, the maximum amount of lidocaine administered should not exceed 4.5 mg/kg (2.0 mg/lb) of body weight ***Lidocaine toxicity resulting from transcutaneous absorption is theoretically possible. Signs and symptoms of systemic lidocaine toxicity include CNS excitation and/or depression, nervousness, confusion, dizziness, tinnitus, blurred or double vision, vomiting, twitching, tremors, seizures, unconsciousness, respiratory depression, bradycardia, hypotension, and cardiopulmonary arrest. If there is suspicion of lidocaine-related systemic toxicity, check lidocaine blood concentrations
QL Criteria 50 grams Per 30 Days
Notes/References
Revision DatePrior Authorization: October 03, 2016Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
353
![Page 354: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/354.jpg)
Lidocaine-Prilocaine
Products Affected• lidocaine-prilocaine external cream
PA Criteria Criteria Details
Covered Uses
***AUTHORIZATION IS NOT REQUIRED FOR LESS THAN 50 GRAMS OF LIDOCAINE EVERY 30 DAYS*** For quantities over 50 grams every 30 days, there must be a documented temporary need for topical anesthetic in either of the following situations: Normal, intact skin for local analgesia, or Genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia
Exclusion Criteria
Documentation of any of the following: Planned area of application includes non-intact skin, Sensitivity to amide-type local anesthetics or any other component of the product, Planned use on large surface area of the body or for a period of time over 3 hours as this can lead to increased toxicity, the medication is being used in conjunction with a cosmetic procedure (i.e. hair removal), Use in situations where the drug may migrate into the middle ear, beyond the tympanic membrane, History of methemoglobinemia, or if the product will be compounded with other products that would alter the total dose/dosage form being administered
Required Medical Information
A documented need for topical anesthetic in either of the following situations: Normal, intact skin for local analgesia, or Genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia
Age Restrictions
Prescriber Restrictions
Coverage Duration
3 months
2018 Aetna Premier Plus Plan01/01/2018
354
![Page 355: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/355.jpg)
PA Criteria Criteria Details
Other Criteria
*Topical lidocaine/prilocaine cream is used for temporary anesthesia. Prescription renewals for longer than 3 months require clinical documentation of medical necessity.Due to Safety Concerns higher quantities and prolonged use are not recommended. Renewal Duration: 3 months *Up to an additional 30 grams per 30 days. Higher additional quantities are not approvable.
QL Criteria 30 grams Per 30 Days
Notes/References
Revision DatePrior Authorization: October 03, 2016Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
355
![Page 356: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/356.jpg)
Lonsurf
Products Affected• LONSURF
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
356
![Page 357: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/357.jpg)
Lorcet
Products Affected• LORCET
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
357
![Page 358: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/358.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
358
![Page 359: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/359.jpg)
Lorcet HD
Products Affected• LORCET HD
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
359
![Page 360: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/360.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
360
![Page 361: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/361.jpg)
Lorcet Plus
Products Affected• LORCET PLUS ORAL TABLET 7.5-325
MG
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
361
![Page 362: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/362.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
362
![Page 363: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/363.jpg)
Lortab
Products Affected• LORTAB ORAL ELIXIR 10-300 MG/15ML• LORTAB ORAL TABLET 10-325 MG, 5-
325 MG, 7.5-325 MG
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
363
![Page 364: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/364.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
364
![Page 365: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/365.jpg)
Low-Ogestrel
Products Affected• LOW-OGESTREL
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
365
![Page 366: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/366.jpg)
Lucentis
Products Affected• LUCENTIS INTRAOCULAR• LUCENTIS INTRAVITREAL SOLUTION
PREFILLED SYRINGE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/EYE/ophthalmic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
366
![Page 367: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/367.jpg)
Lumizyme
Products Affected• LUMIZYME
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/lysosomal_storage.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
367
![Page 368: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/368.jpg)
Lupaneta Pack
Products Affected• LUPANETA PACK
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Gonadotropins.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
368
![Page 369: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/369.jpg)
Lupron Depot (1-Month)
Products Affected• LUPRON DEPOT (1-MONTH)
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Gonadotropins.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
369
![Page 370: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/370.jpg)
Lupron Depot (3-Month)
Products Affected• LUPRON DEPOT (3-MONTH)
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Gonadotropins.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
370
![Page 371: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/371.jpg)
Lupron Depot (4-Month)
Products Affected• LUPRON DEPOT (4-MONTH)
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Gonadotropins.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
371
![Page 372: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/372.jpg)
Lupron Depot (6-Month)
Products Affected• LUPRON DEPOT (6-MONTH)
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Gonadotropins.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
372
![Page 373: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/373.jpg)
Lupron Depot-Ped (1-Month)
Products Affected• LUPRON DEPOT-PED (1-MONTH)
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Gonadotropins.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
373
![Page 374: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/374.jpg)
Lupron Depot-Ped (3-Month)
Products Affected• LUPRON DEPOT-PED (3-MONTH)
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Gonadotropins.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
374
![Page 375: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/375.jpg)
Lutera
Products Affected• LUTERA
QL Criteria 1.5 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
375
![Page 376: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/376.jpg)
Lynparza
Products Affected• LYNPARZA ORAL CAPSULE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 day supply Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
376
![Page 377: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/377.jpg)
Lynparza
Products Affected• LYNPARZA ORAL TABLET
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
377
![Page 378: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/378.jpg)
Macugen
Products Affected• MACUGEN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/EYE/ophthalmic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
378
![Page 379: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/379.jpg)
Makena
Products Affected• MAKENA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/hydroxyprogesterone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
379
![Page 380: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/380.jpg)
Marlissa
Products Affected• marlissa
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
380
![Page 381: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/381.jpg)
Mavyret
Products Affected• MAVYRET
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
381
![Page 382: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/382.jpg)
Mekinist
Products Affected• MEKINIST
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
382
![Page 383: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/383.jpg)
Menopur
Products Affected• MENOPUR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/infertility.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
383
![Page 384: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/384.jpg)
Meperidine HCl
Products Affected• meperidine hcl oral
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
384
![Page 385: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/385.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
385
![Page 386: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/386.jpg)
Metadate CD
Products Affected• METADATE CD
QL Criteria 1 capsule Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
386
![Page 387: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/387.jpg)
Metadate ER
Products Affected• METADATE ER ORAL TABLET
EXTENDED RELEASE 20 MG
QL Criteria 3 tablets Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
387
![Page 388: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/388.jpg)
Methadone HCl
Products Affected• methadone hcl oral
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
388
![Page 389: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/389.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
389
![Page 390: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/390.jpg)
Methadone HCl Intensol
Products Affected• METHADONE HCL INTENSOL
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
390
![Page 391: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/391.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
391
![Page 392: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/392.jpg)
Methadose
Products Affected• METHADOSE ORAL CONCENTRATE 10
MG/ML
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
392
![Page 393: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/393.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
393
![Page 394: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/394.jpg)
Methadose Sugar-Free
Products Affected• METHADOSE SUGAR-FREE
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
394
![Page 395: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/395.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
395
![Page 396: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/396.jpg)
Methamphetamine HCl
Products Affected• methamphetamine hcl
QL Criteria 4 tablets Per 1 Day
Notes/References
Annual Review: 10/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
396
![Page 397: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/397.jpg)
Methylin
Products Affected• METHYLIN ORAL SOLUTION 10
MG/5ML
QL Criteria 30 ML Per 1 Day
Notes/References
Annual Review: 10/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
397
![Page 398: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/398.jpg)
Methylin
Products Affected• METHYLIN ORAL SOLUTION 5
MG/5ML
QL Criteria 60 ML Per 1 Day
Notes/References
Annual Review: 10/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
398
![Page 399: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/399.jpg)
Methylin
Products Affected• METHYLIN ORAL TABLET CHEWABLE
QL Criteria 3 tablets Per 1 Day
Notes/References
Annual Review: 10/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
399
![Page 400: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/400.jpg)
Methylphenidate HCl
Products Affected• methylphenidate hcl oral solution 10 mg/5ml
QL Criteria 30 ML Per 1 Day
Notes/References
Annual Review: 10/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
400
![Page 401: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/401.jpg)
Methylphenidate HCl
Products Affected• methylphenidate hcl oral solution 5 mg/5ml
QL Criteria 60 ML Per 1 Day
Notes/References
Annual Review: 10/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
401
![Page 402: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/402.jpg)
Methylphenidate HCl
Products Affected• methylphenidate hcl oral tablet • methylphenidate hcl oral tablet chewable
QL Criteria 6 tablets Per 1 Day
Notes/References
Annual Review: 10/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
402
![Page 403: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/403.jpg)
Methylphenidate HCl ER
Products Affected• methylphenidate hcl er oral tablet extended
release 10 mg
QL Criteria 3 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
403
![Page 404: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/404.jpg)
Methylphenidate HCl ER
Products Affected• methylphenidate hcl er oral tablet extended
release 18 mg, 27 mg, 54 mg
QL Criteria 2 tablets Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
404
![Page 405: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/405.jpg)
Methylphenidate HCl ER
Products Affected• methylphenidate hcl er oral tablet extended
release 20 mg
QL Criteria 3 tablets Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
405
![Page 406: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/406.jpg)
Methylphenidate HCl ER
Products Affected• methylphenidate hcl er oral tablet extended
release 36 mg
QL Criteria 4 tablets Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
406
![Page 407: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/407.jpg)
Methylphenidate HCl ER
Products Affected• methylphenidate hcl er oral tablet extended
release 24 hour 18 mg, 27 mg, 54 mg
QL Criteria 2 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
407
![Page 408: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/408.jpg)
Methylphenidate HCl ER
Products Affected• methylphenidate hcl er oral tablet extended
release 24 hour 36 mg
QL Criteria 4 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
408
![Page 409: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/409.jpg)
Methylphenidate HCl ER (CD)
Products Affected• methylphenidate hcl er (cd)
QL Criteria 1 capsule Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
409
![Page 410: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/410.jpg)
Methylphenidate HCl ER (LA)
Products Affected• methylphenidate hcl er (la) oral capsule
extended release 24 hour 20 mg• methylphenidate hcl er (la) oral capsule
extended release 24 hour 40 mg
QL Criteria 1 capsule Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
410
![Page 411: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/411.jpg)
Methylphenidate HCl ER (LA)
Products Affected• methylphenidate hcl er (la) oral capsule
extended release 24 hour 30 mg
QL Criteria 2 capsules Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
411
![Page 412: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/412.jpg)
Methylphenidate HCl ER (LA)
Products Affected• methylphenidate hcl er (la) oral capsule
extended release 24 hour 60 mg
QL Criteria 1 capsule Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
412
![Page 413: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/413.jpg)
Microgestin 1.5/30
Products Affected• MICROGESTIN 1.5/30
QL Criteria 1.5 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
413
![Page 414: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/414.jpg)
Microgestin 1/20
Products Affected• MICROGESTIN 1/20
QL Criteria 1.5 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
414
![Page 415: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/415.jpg)
Microgestin FE 1.5/30
Products Affected• MICROGESTIN FE 1.5/30
QL Criteria 1.5 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
415
![Page 416: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/416.jpg)
Microgestin FE 1/20
Products Affected• MICROGESTIN FE 1/20
QL Criteria 1.5 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
416
![Page 417: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/417.jpg)
Mircera
Products Affected• MIRCERA INJECTION SOLUTION
PREFILLED SYRINGE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Erythropoiesis_Stimulating_Agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
417
![Page 418: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/418.jpg)
Monoclate-P
Products Affected• MONOCLATE-P
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
418
![Page 419: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/419.jpg)
Mononine
Products Affected• MONONINE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
419
![Page 420: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/420.jpg)
Monovisc
Products Affected• MONOVISC
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/viscosupplements.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
420
![Page 421: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/421.jpg)
MorphaBond ER
Products Affected• MORPHABOND ER
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
421
![Page 422: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/422.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
422
![Page 423: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/423.jpg)
Morphine Sulfate
Products Affected• morphine sulfate oral • morphine sulfate rectal
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
423
![Page 424: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/424.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
424
![Page 425: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/425.jpg)
Morphine Sulfate (Concentrate)
Products Affected• morphine sulfate (concentrate) oral solution
100 mg/5ml, 20 mg/ml
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
425
![Page 426: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/426.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
426
![Page 427: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/427.jpg)
Morphine Sulfate ER
Products Affected• morphine sulfate er oral capsule extended
release 24 hour• morphine sulfate er oral tablet extended
release
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
427
![Page 428: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/428.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
428
![Page 429: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/429.jpg)
Morphine Sulfate ER Beads
Products Affected• morphine sulfate er beads
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
429
![Page 430: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/430.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
430
![Page 431: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/431.jpg)
MS Contin
Products Affected• MS CONTIN ORAL TABLET EXTENDED
RELEASE
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
431
![Page 432: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/432.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
432
![Page 433: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/433.jpg)
Myalept
Products Affected• MYALEPT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/myalept.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
433
![Page 434: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/434.jpg)
Mydayis
Products Affected• MYDAYIS
QL Criteria 1 capsule Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
434
![Page 435: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/435.jpg)
Myorisan
Products Affected• MYORISAN
PA Criteria Criteria Details
Covered Uses Severe recalcitrant nodular or cystic acne
Exclusion Criteria
Required Medical Information
Member is enrolled in the FDA iPLEDGE program and, because of significant adverse reactions associated with its use, should be reserved for patients with multiple severe nodular acne who are unresponsive to conventional therapy, including topical acne products and systemic antibiotics
Age Restrictions
Prescriber Restrictions
Coverage Duration
1 year
Other Criteria
QL Criteria 2 capsules Per 1 Day
Notes/References
Revision DatePrior Authorization: August 22, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
435
![Page 436: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/436.jpg)
Myorisan
Products Affected• MYORISAN
PA Criteria Criteria Details
Covered Uses Severe recalcitrant nodular or cystic acne
Exclusion Criteria
Required Medical Information
Member is enrolled in the FDA iPLEDGE program and, because of significant adverse reactions associated with its use, should be reserved for patients with multiple severe nodular acne who are unresponsive to conventional therapy, including topical acne products and systemic antibiotics
Age Restrictions
Prescriber Restrictions
Coverage Duration
1 year
Other Criteria
QL Criteria 2 capsules Per 1 Day
Notes/References
Annual Review: 02/2017
Revision DatePrior Authorization: August 22, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
436
![Page 437: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/437.jpg)
Myozyme
Products Affected• MYOZYME
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/lysosomal_storage.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
437
![Page 438: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/438.jpg)
Naglazyme
Products Affected• NAGLAZYME
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/lysosomal_storage.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
438
![Page 439: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/439.jpg)
Natpara
Products Affected• NATPARA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/bone_disease_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
439
![Page 440: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/440.jpg)
Necon 0.5/35 (28)
Products Affected• NECON 0.5/35 (28)
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
440
![Page 441: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/441.jpg)
Necon 1/35 (28)
Products Affected• NECON 1/35 (28)
QL Criteria 1.5 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
441
![Page 442: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/442.jpg)
Necon 10/11 (28)
Products Affected• NECON 10/11 (28)
QL Criteria 1.5 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
442
![Page 443: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/443.jpg)
Nerlynx
Products Affected• NERLYNX
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Nerlynx.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
443
![Page 444: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/444.jpg)
Neulasta
Products Affected• NEULASTA SUBCUTANEOUS
SOLUTION PREFILLED SYRINGE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/G-CSF.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
444
![Page 445: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/445.jpg)
Neulasta Delivery Kit
Products Affected• NEULASTA DELIVERY KIT
SUBCUTANEOUS PREFILLED SYRINGE KIT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/G-CSF.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
445
![Page 446: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/446.jpg)
Neumega
Products Affected• NEUMEGA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Neumega.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
446
![Page 447: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/447.jpg)
Neupogen
Products Affected• NEUPOGEN INJECTION SOLUTION 300
MCG/ML, 480 MCG/1.6ML• NEUPOGEN INJECTION SOLUTION
PREFILLED SYRINGE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/G-CSF.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
447
![Page 448: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/448.jpg)
NexAVAR
Products Affected• NEXAVAR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
448
![Page 449: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/449.jpg)
Ninlaro
Products Affected• NINLARO
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
449
![Page 450: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/450.jpg)
Nityr
Products Affected• NITYR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/metabolic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
450
![Page 451: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/451.jpg)
Norco
Products Affected• NORCO
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
451
![Page 452: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/452.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
452
![Page 453: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/453.jpg)
Norditropin FlexPro
Products Affected• NORDITROPIN FLEXPRO
SUBCUTANEOUS SOLUTION 10 MG/1.5ML, 15 MG/1.5ML, 5 MG/1.5ML
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
453
![Page 454: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/454.jpg)
Norditropin NordiFlex Pen
Products Affected• NORDITROPIN NORDIFLEX PEN
SUBCUTANEOUS SOLUTION 30 MG/3ML
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
454
![Page 455: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/455.jpg)
Norgestrel-Ethinyl Estradiol
Products Affected• norgestrel-ethinyl estradiol
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
455
![Page 456: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/456.jpg)
Northera
Products Affected• NORTHERA ORAL CAPSULE 100 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/Northera.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 3 capsules Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
456
![Page 457: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/457.jpg)
Northera
Products Affected• NORTHERA ORAL CAPSULE 200 MG,
300 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/Northera.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 6 capsules Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
457
![Page 458: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/458.jpg)
Nortrel 0.5/35 (28)
Products Affected• NORTREL 0.5/35 (28)
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
458
![Page 459: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/459.jpg)
Nortrel 1/35 (21)
Products Affected• NORTREL 1/35 (21)
QL Criteria 1.5 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
459
![Page 460: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/460.jpg)
Nortrel 1/35 (28)
Products Affected• NORTREL 1/35 (28)
QL Criteria 1.5 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
460
![Page 461: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/461.jpg)
Novarel
Products Affected• novarel intramuscular solution reconstituted
10000 unit
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/infertility.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
461
![Page 462: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/462.jpg)
Novoeight
Products Affected• NOVOEIGHT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
462
![Page 463: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/463.jpg)
NovoSeven RT
Products Affected• NOVOSEVEN RT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
463
![Page 464: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/464.jpg)
Nplate
Products Affected• NPLATE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Neumega.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
464
![Page 465: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/465.jpg)
Nucala
Products Affected• NUCALA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/RESP/Interleukin Antagonist.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
465
![Page 466: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/466.jpg)
Nucynta
Products Affected• NUCYNTA
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
466
![Page 467: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/467.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Annual Review: 06/2017
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
467
![Page 468: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/468.jpg)
Nucynta ER
Products Affected• NUCYNTA ER
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
468
![Page 469: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/469.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Annual Review: 06/2017
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
469
![Page 470: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/470.jpg)
Nuplazid
Products Affected• NUPLAZID
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/Nuplazid.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
470
![Page 471: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/471.jpg)
Nutropin
Products Affected• NUTROPIN SUBCUTANEOUS
SOLUTION RECONSTITUTED 10 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
471
![Page 472: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/472.jpg)
Nutropin AQ
Products Affected• NUTROPIN AQ
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
472
![Page 473: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/473.jpg)
Nutropin AQ NuSpin 10
Products Affected• NUTROPIN AQ NUSPIN 10
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
473
![Page 474: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/474.jpg)
Nutropin AQ NuSpin 20
Products Affected• NUTROPIN AQ NUSPIN 20
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
474
![Page 475: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/475.jpg)
Nutropin AQ NuSpin 5
Products Affected• NUTROPIN AQ NUSPIN 5
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
475
![Page 476: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/476.jpg)
Nutropin AQ Pen
Products Affected• NUTROPIN AQ PEN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
476
![Page 477: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/477.jpg)
Nuwiq
Products Affected• NUWIQ INTRAVENOUS KIT 1000 UNIT,
2000 UNIT, 250 UNIT, 500 UNIT• NUWIQ INTRAVENOUS SOLUTION
RECONSTITUTED 1000 UNIT, 2000 UNIT, 250 UNIT, 500 UNIT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
477
![Page 478: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/478.jpg)
Ocaliva
Products Affected• OCALIVA ORAL TABLET 5 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/Primary_Biliary_Cholagitis.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
478
![Page 479: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/479.jpg)
Octagam
Products Affected• OCTAGAM
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/ivig.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
479
![Page 480: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/480.jpg)
Octreotide Acetate
Products Affected• octreotide acetate
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/Sandostatin.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
480
![Page 481: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/481.jpg)
Odomzo
Products Affected• ODOMZO
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Odomzo.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
481
![Page 482: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/482.jpg)
Ofev
Products Affected• OFEV
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Idiopathic_Pulmonary_Fibrosis.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 2 capsules Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
482
![Page 483: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/483.jpg)
Olysio
Products Affected• OLYSIO
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 1 capsule Per 1 Day
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
483
![Page 484: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/484.jpg)
Omnitrope
Products Affected• OMNITROPE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
484
![Page 485: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/485.jpg)
Opana
Products Affected• OPANA ORAL
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
485
![Page 486: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/486.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
486
![Page 487: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/487.jpg)
Opana ER
Products Affected• OPANA ER ORAL TABLET ER 12 HOUR
ABUSE-DETERRENT
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
487
![Page 488: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/488.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Annual Review: 06/2017
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
488
![Page 489: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/489.jpg)
Opsumit
Products Affected• OPSUMIT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 1 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
489
![Page 490: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/490.jpg)
Orencia
Products Affected• ORENCIA INTRAVENOUS• ORENCIA SUBCUTANEOUS SOLUTION
PREFILLED SYRINGE 50 MG/0.4ML, 87.5 MG/0.7ML
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Orencia.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
490
![Page 491: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/491.jpg)
Orencia
Products Affected• ORENCIA SUBCUTANEOUS SOLUTION
PREFILLED SYRINGE 125 MG/ML
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Orencia.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 4 syringes Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
491
![Page 492: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/492.jpg)
Orencia ClickJect
Products Affected• ORENCIA CLICKJECT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Orencia.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
492
![Page 493: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/493.jpg)
Orenitram
Products Affected• ORENITRAM
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
493
![Page 494: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/494.jpg)
Orfadin
Products Affected• ORFADIN ORAL CAPSULE 10 MG, 2
MG, 5 MG• ORFADIN ORAL SUSPENSION
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/metabolic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
494
![Page 495: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/495.jpg)
Orkambi
Products Affected• ORKAMBI
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/cystic_fibrosis.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
495
![Page 496: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/496.jpg)
Orsythia
Products Affected• ORSYTHIA
QL Criteria 1.5 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
496
![Page 497: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/497.jpg)
OrthoVisc
Products Affected• ORTHOVISC INTRA-ARTICULAR
SOLUTION PREFILLED SYRINGE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/viscosupplements.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
497
![Page 498: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/498.jpg)
Otezla
Products Affected• OTEZLA ORAL TABLET• OTEZLA ORAL TABLET THERAPY
PACK
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Otezla.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
498
![Page 499: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/499.jpg)
Ovidrel
Products Affected• OVIDREL
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/infertility.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
499
![Page 500: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/500.jpg)
Oxaydo
Products Affected• OXAYDO
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
500
![Page 501: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/501.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
501
![Page 502: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/502.jpg)
OxyCODONE HCl
Products Affected• oxycodone hcl oral capsule• oxycodone hcl oral concentrate 100 mg/5ml• oxycodone hcl oral concentrate 20 mg/ml
• oxycodone hcl oral solution• oxycodone hcl oral tablet
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
502
![Page 503: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/503.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
503
![Page 504: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/504.jpg)
OxyCODONE HCl ER
Products Affected• oxycodone hcl er oral tablet er 12 hour
abuse-deterrent
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
504
![Page 505: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/505.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
505
![Page 506: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/506.jpg)
OxyCODONE HCl ER
Products Affected• oxycodone hcl er oral tablet er 12 hour
abuse-deterrent
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
506
![Page 507: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/507.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Annual Review: 06/2017
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
507
![Page 508: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/508.jpg)
Oxycodone-Acetaminophen
Products Affected• oxycodone-acetaminophen oral solution• oxycodone-acetaminophen oral tablet 10-325
mg, 2.5-325 mg, 5-325 mg, 7.5-325 mg
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
508
![Page 509: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/509.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
509
![Page 510: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/510.jpg)
Oxycodone-Aspirin
Products Affected• oxycodone-aspirin oral tablet 4.8355-325 mg
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
510
![Page 511: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/511.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
511
![Page 512: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/512.jpg)
Oxycodone-Ibuprofen
Products Affected• oxycodone-ibuprofen
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
512
![Page 513: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/513.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
513
![Page 514: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/514.jpg)
OxyCONTIN
Products Affected• OXYCONTIN ORAL TABLET ER 12
HOUR ABUSE-DETERRENT
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
514
![Page 515: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/515.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Annual Review: 06/2017
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
515
![Page 516: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/516.jpg)
Oxymorphone HCl
Products Affected• oxymorphone hcl
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
516
![Page 517: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/517.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
517
![Page 518: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/518.jpg)
OxyMORphone HCl ER
Products Affected• oxymorphone hcl er
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
518
![Page 519: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/519.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
519
![Page 520: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/520.jpg)
Ozurdex
Products Affected• OZURDEX INTRAOCULAR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/EYE/ophthalmic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
520
![Page 521: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/521.jpg)
Pegasys
Products Affected• PEGASYS
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
521
![Page 522: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/522.jpg)
Pegasys ProClick
Products Affected• PEGASYS PROCLICK
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
522
![Page 523: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/523.jpg)
PegIntron
Products Affected• PEGINTRON
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
523
![Page 524: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/524.jpg)
Peg-Intron
Products Affected• PEG-INTRON
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
524
![Page 525: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/525.jpg)
Peg-Intron Redipen
Products Affected• PEG-INTRON REDIPEN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
525
![Page 526: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/526.jpg)
Peg-Intron Redipen Pak 4
Products Affected• PEG-INTRON REDIPEN PAK 4
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
526
![Page 527: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/527.jpg)
Pentazocine-Naloxone HCl
Products Affected• pentazocine-naloxone hcl
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
527
![Page 528: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/528.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
528
![Page 529: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/529.jpg)
Percocet
Products Affected• PERCOCET ORAL TABLET 10-325 MG,
2.5-325 MG, 5-325 MG, 7.5-325 MG
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
529
![Page 530: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/530.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
530
![Page 531: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/531.jpg)
Phenoxybenzamine HCl
Products Affected• phenoxybenzamine hcl oral
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/antihypertensive_misc.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
531
![Page 532: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/532.jpg)
Philith
Products Affected• PHILITH
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
532
![Page 533: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/533.jpg)
Plegridy
Products Affected• PLEGRIDY
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/MSinterferons.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 1 ML Per 28 Days
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
533
![Page 534: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/534.jpg)
Plegridy Starter Pack
Products Affected• PLEGRIDY STARTER PACK
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/MSinterferons.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 1 ML Per 28 Days
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
534
![Page 535: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/535.jpg)
Pomalyst
Products Affected• POMALYST
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
535
![Page 536: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/536.jpg)
Portia-28
Products Affected• PORTIA-28
QL Criteria 1.5 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
536
![Page 537: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/537.jpg)
Praluent
Products Affected• PRALUENT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/PCSK9.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
537
![Page 538: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/538.jpg)
Pregnyl
Products Affected• pregnyl
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/infertility.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
538
![Page 539: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/539.jpg)
Primlev
Products Affected• PRIMLEV
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
539
![Page 540: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/540.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
540
![Page 541: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/541.jpg)
Privigen
Products Affected• PRIVIGEN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/ivig.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
541
![Page 542: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/542.jpg)
ProCentra
Products Affected• PROCENTRA
QL Criteria 40 ML Per 1 Day
Notes/References
Annual Review: 10/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
542
![Page 543: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/543.jpg)
Procrit
Products Affected• PROCRIT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Erythropoiesis_Stimulating_Agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
543
![Page 544: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/544.jpg)
Procysbi
Products Affected• PROCYSBI ORAL CAPSULE DELAYED
RELEASE 25 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/lysosomal_storage.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 4 capsules Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
544
![Page 545: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/545.jpg)
Procysbi
Products Affected• PROCYSBI ORAL CAPSULE DELAYED
RELEASE 75 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/lysosomal_storage.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 25 capsules Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
545
![Page 546: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/546.jpg)
Profilnine SD
Products Affected• PROFILNINE SD
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
546
![Page 547: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/547.jpg)
Prolastin-C
Products Affected• PROLASTIN-C INTRAVENOUS
SOLUTION RECONSTITUTED 1000 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/Alpha-1 Antitrypsin Inhibitor Therapy.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
547
![Page 548: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/548.jpg)
Prolia
Products Affected• PROLIA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/bone_disease_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
548
![Page 549: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/549.jpg)
Promacta
Products Affected• PROMACTA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Promacta.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
549
![Page 550: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/550.jpg)
Prudoxin
Products Affected• PRUDOXIN
QL Criteria 45 grams Per 30 Days
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
550
![Page 551: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/551.jpg)
Pulmozyme
Products Affected• PULMOZYME
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/cystic_fibrosis.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
551
![Page 552: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/552.jpg)
Purixan
Products Affected• PURIXAN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
552
![Page 553: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/553.jpg)
QuilliChew ER
Products Affected• QUILLICHEW ER ORAL TABLET
CHEWABLE EXTENDED RELEASE 20 MG, 40 MG
QL Criteria 1 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
553
![Page 554: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/554.jpg)
QuilliChew ER
Products Affected• QUILLICHEW ER ORAL TABLET
CHEWABLE EXTENDED RELEASE 30 MG
QL Criteria 2 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
554
![Page 555: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/555.jpg)
Quillivant XR
Products Affected• QUILLIVANT XR
QL Criteria 12 ML Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
555
![Page 556: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/556.jpg)
Ravicti
Products Affected• RAVICTI
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/metabolic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
556
![Page 557: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/557.jpg)
Rebif
Products Affected• REBIF SUBCUTANEOUS SOLUTION
PREFILLED SYRINGE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/MSinterferons.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
557
![Page 558: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/558.jpg)
Rebif Rebidose
Products Affected• REBIF REBIDOSE SUBCUTANEOUS
SOLUTION AUTO-INJECTOR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/MSinterferons.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
558
![Page 559: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/559.jpg)
Rebif Rebidose Titration Pack
Products Affected• REBIF REBIDOSE TITRATION PACK
SUBCUTANEOUS SOLUTION AUTO-INJECTOR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/MSinterferons.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
559
![Page 560: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/560.jpg)
Rebif Titration Pack
Products Affected• REBIF TITRATION PACK
SUBCUTANEOUS SOLUTION PREFILLED SYRINGE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/MSinterferons.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
560
![Page 561: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/561.jpg)
Reclipsen
Products Affected• RECLIPSEN
QL Criteria 1.5 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
561
![Page 562: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/562.jpg)
Recombinate
Products Affected• RECOMBINATE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
562
![Page 563: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/563.jpg)
Remicade
Products Affected• REMICADE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Remicade.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
563
![Page 564: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/564.jpg)
Remodulin
Products Affected• REMODULIN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
564
![Page 565: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/565.jpg)
Renflexis
Products Affected• RENFLEXIS
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Renflexis.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
565
![Page 566: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/566.jpg)
Repatha
Products Affected• REPATHA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/PCSK9.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
566
![Page 567: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/567.jpg)
Repatha Pushtronex System
Products Affected• REPATHA PUSHTRONEX SYSTEM
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/PCSK9.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
567
![Page 568: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/568.jpg)
Repatha SureClick
Products Affected• REPATHA SURECLICK
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/PCSK9.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
568
![Page 569: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/569.jpg)
Reprexain
Products Affected• REPREXAIN ORAL TABLET 10-200 MG,
5-200 MG
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
569
![Page 570: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/570.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
570
![Page 571: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/571.jpg)
Repronex
Products Affected• REPRONEX
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/infertility.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
571
![Page 572: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/572.jpg)
Revatio
Products Affected• REVATIO INTRAVENOUS
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
572
![Page 573: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/573.jpg)
Revatio
Products Affected• REVATIO ORAL SUSPENSION
RECONSTITUTED
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 2 bottles Per 30 Days
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
573
![Page 574: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/574.jpg)
Revatio
Products Affected• REVATIO ORAL TABLET
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 3 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
574
![Page 575: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/575.jpg)
Revlimid
Products Affected• REVLIMID
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
575
![Page 576: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/576.jpg)
RiaSTAP
Products Affected• RIASTAP
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Riastap.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
576
![Page 577: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/577.jpg)
Ritalin
Products Affected• RITALIN
QL Criteria 6 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
577
![Page 578: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/578.jpg)
Ritalin LA
Products Affected• RITALIN LA ORAL CAPSULE
EXTENDED RELEASE 24 HOUR 10 MG, 20 MG, 40 MG, 60 MG
QL Criteria 1 capsule Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
578
![Page 579: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/579.jpg)
Ritalin LA
Products Affected• RITALIN LA ORAL CAPSULE
EXTENDED RELEASE 24 HOUR 30 MG
QL Criteria 2 capsule Per 1 Day
Notes/References
Annual Review: 09/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
579
![Page 580: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/580.jpg)
Rixubis
Products Affected• RIXUBIS
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
580
![Page 581: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/581.jpg)
Rosuvastatin Calcium
Products Affected• rosuvastatin calcium
QL Criteria 1 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
581
![Page 582: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/582.jpg)
Roxicet
Products Affected• ROXICET ORAL SOLUTION
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
582
![Page 583: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/583.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
583
![Page 584: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/584.jpg)
Roxicodone
Products Affected• ROXICODONE ORAL TABLET
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
584
![Page 585: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/585.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
585
![Page 586: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/586.jpg)
Rubraca
Products Affected• RUBRACA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Rubraca.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
586
![Page 587: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/587.jpg)
Ruconest
Products Affected• RUCONEST
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/hereditary_angioedema.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
587
![Page 588: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/588.jpg)
Rydapt
Products Affected• RYDAPT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Rydapt.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
588
![Page 589: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/589.jpg)
Sabril
Products Affected• SABRIL
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/anticonvulsants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
589
![Page 590: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/590.jpg)
Saizen
Products Affected• SAIZEN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
590
![Page 591: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/591.jpg)
Saizen Click.Easy
Products Affected• SAIZEN CLICK.EASY
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
591
![Page 592: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/592.jpg)
Samsca
Products Affected• SAMSCA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/samsca.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
592
![Page 593: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/593.jpg)
SandoSTATIN
Products Affected• SANDOSTATIN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/Sandostatin.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
593
![Page 594: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/594.jpg)
SandoSTATIN LAR Depot
Products Affected• SANDOSTATIN LAR DEPOT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/Sandostatin.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
594
![Page 595: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/595.jpg)
Serostim
Products Affected• SEROSTIM SUBCUTANEOUS
SOLUTION RECONSTITUTED 4 MG, 5 MG, 6 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
595
![Page 596: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/596.jpg)
Signifor
Products Affected• SIGNIFOR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/Signifor.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 10 ampules Per 30 Days
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
596
![Page 597: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/597.jpg)
Signifor LAR
Products Affected• SIGNIFOR LAR INTRAMUSCULAR
SUSPENSION RECONSTITUTED
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/Signifor.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 1 injection Per 28 Days
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
597
![Page 598: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/598.jpg)
Sildenafil Citrate
Products Affected• sildenafil citrate oral
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
598
![Page 599: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/599.jpg)
Siliq
Products Affected• SILIQ
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Siliq.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
599
![Page 600: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/600.jpg)
Simponi
Products Affected• SIMPONI SUBCUTANEOUS SOLUTION
AUTO-INJECTOR• SIMPONI SUBCUTANEOUS SOLUTION
PREFILLED SYRINGE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Simponi.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 1 syringe Per 30 Days
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
600
![Page 601: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/601.jpg)
Simponi Aria
Products Affected• SIMPONI ARIA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Simponi_Aria.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
601
![Page 602: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/602.jpg)
Sirturo
Products Affected• SIRTURO
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ID/antimycobacterial_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 68 tablets Per 30 Days
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
602
![Page 603: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/603.jpg)
Sodium Phenylbutyrate
Products Affected• sodium phenylbutyrate oral powder 3 gm/tsp
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/metabolic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
603
![Page 604: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/604.jpg)
Solaraze
Products Affected• SOLARAZE
PA Criteria Criteria Details
Covered Uses Actinic keratoses (AK)
Exclusion Criteria
Documentation of any of the following patients/situations: use in treatment of postoperative pain after coronary artery bypass graft (CABG) surgery, any known hypersensitivity to diclofenac or any component of the formulation, any history of Asthma and aspirin triad, the planned area of application includes non-intact skin, or if the medication will be compounded with other products that would alter the total dose/dosage form being administered
Required Medical Information
Documentation that sun avoidance is indicated during therapy
Age Restrictions
Prescriber Restrictions
Coverage Duration
1 year
Other Criteria
QL Criteria 100 grams Per 30 Days
Notes/References
Revision DatePrior Authorization: September 29, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
604
![Page 605: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/605.jpg)
Soliris
Products Affected• SOLIRIS
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/soliris.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
605
![Page 606: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/606.jpg)
Somatuline Depot
Products Affected• SOMATULINE DEPOT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/Sandostatin.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
606
![Page 607: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/607.jpg)
Somavert
Products Affected• SOMAVERT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
607
![Page 608: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/608.jpg)
Sovaldi
Products Affected• SOVALDI
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 1 tab Per 1 fill
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
608
![Page 609: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/609.jpg)
Sprycel
Products Affected• SPRYCEL
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
609
![Page 610: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/610.jpg)
Sronyx
Products Affected• SRONYX
QL Criteria 1.5 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
610
![Page 611: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/611.jpg)
Stelara
Products Affected• STELARA INTRAVENOUS• STELARA SUBCUTANEOUS SOLUTION
PREFILLED SYRINGE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Stelara.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
611
![Page 612: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/612.jpg)
Stiolto Respimat
Products Affected• STIOLTO RESPIMAT
QL Criteria 1 inhaler Per 30 Days
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
612
![Page 613: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/613.jpg)
Stivarga
Products Affected• STIVARGA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 21 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
613
![Page 614: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/614.jpg)
Strattera
Products Affected• STRATTERA ORAL CAPSULE 10 MG, 18
MG, 25 MG, 40 MG, 60 MG
QL Criteria 2 capsules Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
614
![Page 615: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/615.jpg)
Strattera
Products Affected• STRATTERA ORAL CAPSULE 100 MG,
80 MG
QL Criteria 1 capsule Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
615
![Page 616: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/616.jpg)
Strensiq
Products Affected• STRENSIQ
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/lysosomal_storage.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
616
![Page 617: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/617.jpg)
Suboxone
Products Affected• SUBOXONE SUBLINGUAL FILM 12-3
MG
QL Criteria 2 films Per 1 Day
Notes/References
Annual Review: 04/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
617
![Page 618: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/618.jpg)
Suboxone
Products Affected• SUBOXONE SUBLINGUAL FILM 2-0.5
MG, 4-1 MG, 8-2 MG
QL Criteria 90 films Per 30 Days
Notes/References
Annual Review: 04/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
618
![Page 619: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/619.jpg)
Suboxone
Products Affected• SUBOXONE SUBLINGUAL TABLET
SUBLINGUAL
QL Criteria 2 tablets Per 1 Day
Notes/References
Annual Review: 04/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
619
![Page 620: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/620.jpg)
Subsys
Products Affected• SUBSYS
PA Criteria Criteria Details
Covered Uses Breakthrough cancer pain, General anesthesia
Exclusion Criteria
Required Medical Information
A documented diagnosis of cancer and concomitant use of long acting opioid therapy or member's resident state or contract state is California and the member is terminally ill
Age Restrictions
Prescriber Restrictions
Coverage Duration
1 year
2018 Aetna Premier Plus Plan01/01/2018
620
![Page 621: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/621.jpg)
PA Criteria Criteria Details
Other Criteria
For coverage of additional quantities, member must meet the following requirements: A Documented diagnosis of cancer and prescription is written by an oncologist or pain specialist, or member is enrolled in a hospice program or meets hospice criteria, or member's resident state or contract state is California and the member is terminally ill, or the patient has signed opioid agreement in support of clinical guidelines by the American Pain Society and the American Academy of Pain Medicine, Healthcare Provider verbal confirmation that an agreement has been signed by the patient meets the criteria requirement.*Exceptions to requiring the signed opioid agreement for additional quantities are only for those patients that have a diagnosis of cancer or that are enrolled in a hospice program and documentation of one of the following: Member has current diagnosis of cancer(*see exception to opioid agreement above) as the primary cause of the pain and is currently on long-acting opioid and is being titrated on the long-acting opioid by physician, and member has tried and failed an adequate trial of two weeks of a single entity or combination pain medication containing an immediate release acting opioid (ex. oxycodone, morphine sulfate oral(Roxanol), oxymorphone(Opana), hydromorphone(Dilaudid), oxycodone/apap(Percocet))
QL Criteria 120 sprays Per 30 Days
Notes/References
Annual Review: 06/2017
Revision DatePrior Authorization: April 25, 2016Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
621
![Page 622: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/622.jpg)
Supartz
Products Affected• SUPARTZ INTRA-ARTICULAR
SOLUTION PREFILLED SYRINGE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/viscosupplements.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
622
![Page 623: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/623.jpg)
Supprelin LA
Products Affected• SUPPRELIN LA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Gonadotropins.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
623
![Page 624: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/624.jpg)
Sutent
Products Affected• SUTENT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
624
![Page 625: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/625.jpg)
Sylatron
Products Affected• SYLATRON SUBCUTANEOUS KIT 200
MCG, 300 MCG, 4 X 200 MCG, 4 X 300 MCG, 600 MCG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
625
![Page 626: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/626.jpg)
Synagis
Products Affected• SYNAGIS
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Synagis.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
626
![Page 627: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/627.jpg)
Synalgos-DC
Products Affected• SYNALGOS-DC
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
627
![Page 628: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/628.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
628
![Page 629: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/629.jpg)
Synarel
Products Affected• SYNAREL
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Gonadotropins.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
629
![Page 630: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/630.jpg)
Synvisc
Products Affected• SYNVISC INTRA-ARTICULAR
SOLUTION PREFILLED SYRINGE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/viscosupplements.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
630
![Page 631: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/631.jpg)
Synvisc One
Products Affected• SYNVISC ONE INTRA-ARTICULAR
SOLUTION PREFILLED SYRINGE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/viscosupplements.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
631
![Page 632: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/632.jpg)
Syprine
Products Affected• SYPRINE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/metabolic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
632
![Page 633: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/633.jpg)
Tacrolimus
Products Affected• tacrolimus external
QL Criteria 60 GM Per 1 fill
Notes/References
Annual Review: 06/2017
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
633
![Page 634: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/634.jpg)
Tafinlar
Products Affected• TAFINLAR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
634
![Page 635: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/635.jpg)
Tagrisso
Products Affected• TAGRISSO
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Tagrisso.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
635
![Page 636: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/636.jpg)
Taltz
Products Affected• TALTZ
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Taltz.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
636
![Page 637: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/637.jpg)
Tarceva
Products Affected• TARCEVA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
637
![Page 638: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/638.jpg)
Targretin
Products Affected• TARGRETIN ORAL
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Targretin.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
638
![Page 639: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/639.jpg)
Tasigna
Products Affected• TASIGNA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
639
![Page 640: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/640.jpg)
Tecfidera
Products Affected• TECFIDERA ORAL
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/Tecfidera.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 1 starter pack Per 30 Days
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
640
![Page 641: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/641.jpg)
Tecfidera
Products Affected• TECFIDERA ORAL CAPSULE DELAYED
RELEASE 120 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/Tecfidera.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 14 capsules Per 7 Days
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
641
![Page 642: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/642.jpg)
Tecfidera
Products Affected• TECFIDERA ORAL CAPSULE DELAYED
RELEASE 240 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/Tecfidera.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 2 capsules Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
642
![Page 643: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/643.jpg)
Technivie
Products Affected• TECHNIVIE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
643
![Page 644: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/644.jpg)
Temodar
Products Affected• TEMODAR ORAL
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
644
![Page 645: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/645.jpg)
Temozolomide
Products Affected• temozolomide
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
645
![Page 646: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/646.jpg)
Tetrabenazine
Products Affected• tetrabenazine
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/xenazine.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
646
![Page 647: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/647.jpg)
Tev-Tropin
Products Affected• TEV-TROPIN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
647
![Page 648: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/648.jpg)
Thalomid
Products Affected• THALOMID
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
648
![Page 649: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/649.jpg)
Thiola
Products Affected• THIOLA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/metabolic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
649
![Page 650: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/650.jpg)
Tilia Fe
Products Affected• TILIA FE
QL Criteria 1.5 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
650
![Page 651: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/651.jpg)
Tracleer
Products Affected• TRACLEER
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
651
![Page 652: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/652.jpg)
TraMADol HCl
Products Affected• tramadol hcl oral
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
652
![Page 653: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/653.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
653
![Page 654: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/654.jpg)
TraMADol HCl ER
Products Affected• tramadol hcl er
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
654
![Page 655: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/655.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
655
![Page 656: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/656.jpg)
TraMADol HCl ER (Biphasic)
Products Affected• tramadol hcl er (biphasic)
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
656
![Page 657: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/657.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
657
![Page 658: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/658.jpg)
Tramadol-Acetaminophen
Products Affected• tramadol-acetaminophen
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
658
![Page 659: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/659.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
659
![Page 660: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/660.jpg)
Trelstar
Products Affected• TRELSTAR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Gonadotropins.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
660
![Page 661: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/661.jpg)
Trelstar Mixject
Products Affected• TRELSTAR MIXJECT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Gonadotropins.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
661
![Page 662: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/662.jpg)
Tremfya
Products Affected• TREMFYA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Tremfya.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
662
![Page 663: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/663.jpg)
Tretten
Products Affected• TRETTEN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
663
![Page 664: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/664.jpg)
Trezix
Products Affected• TREZIX ORAL CAPSULE 320.5-30-16 MG
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
664
![Page 665: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/665.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
665
![Page 666: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/666.jpg)
Tri-Legest Fe
Products Affected• TRI-LEGEST FE
QL Criteria 1.5 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
666
![Page 667: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/667.jpg)
Trivora (28)
Products Affected• TRIVORA (28)
QL Criteria 1.5 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
667
![Page 668: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/668.jpg)
Truvada
Products Affected• TRUVADA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ID/antiviral_hiv.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
668
![Page 669: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/669.jpg)
Tykerb
Products Affected• TYKERB
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
669
![Page 670: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/670.jpg)
Tylenol with Codeine #3
Products Affected• TYLENOL WITH CODEINE #3
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
670
![Page 671: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/671.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
671
![Page 672: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/672.jpg)
Tylenol with Codeine #4
Products Affected• TYLENOL WITH CODEINE #4
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
672
![Page 673: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/673.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
673
![Page 674: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/674.jpg)
Tymlos
Products Affected• TYMLOS
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/bone_disease_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 1 pen Per 1 month
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
674
![Page 675: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/675.jpg)
Tysabri
Products Affected• TYSABRI
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/Tysabri.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
675
![Page 676: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/676.jpg)
Tyvaso
Products Affected• TYVASO
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
676
![Page 677: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/677.jpg)
Tyvaso Refill
Products Affected• TYVASO REFILL
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
677
![Page 678: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/678.jpg)
Tyvaso Starter
Products Affected• TYVASO STARTER
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
678
![Page 679: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/679.jpg)
Ultracet
Products Affected• ULTRACET
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
679
![Page 680: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/680.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
680
![Page 681: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/681.jpg)
Ultram
Products Affected• ULTRAM
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
681
![Page 682: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/682.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
682
![Page 683: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/683.jpg)
Ultram ER
Products Affected• ULTRAM ER ORAL TABLET
EXTENDED RELEASE 24 HOUR 100 MG, 300 MG
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
2018 Aetna Premier Plus Plan01/01/2018
683
![Page 684: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/684.jpg)
PA Criteria Criteria Details
Other Criteria
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
684
![Page 685: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/685.jpg)
Uptravi
Products Affected• UPTRAVI
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
685
![Page 686: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/686.jpg)
Valchlor
Products Affected• VALCHLOR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
686
![Page 687: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/687.jpg)
Valcyte
Products Affected• VALCYTE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ID/antiviraloraltopical.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
687
![Page 688: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/688.jpg)
ValGANciclovir HCl
Products Affected• valganciclovir hcl
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ID/antiviraloraltopical.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
688
![Page 689: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/689.jpg)
Vantas
Products Affected• VANTAS
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Gonadotropins.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
689
![Page 690: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/690.jpg)
Vecamyl
Products Affected• VECAMYL
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/antihypertensive_misc.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 10 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
690
![Page 691: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/691.jpg)
Veletri
Products Affected• VELETRI
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
691
![Page 692: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/692.jpg)
Velivet
Products Affected• VELIVET
QL Criteria 1.5 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
692
![Page 693: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/693.jpg)
Veltassa
Products Affected• VELTASSA
PA Criteria Criteria Details
Covered Uses Treatment of hyperkalemia
Exclusion Criteria
Required Medical Information
Documentation that a member (at least 18 years of age) has a diagnosis of chronic kidney disease (CKD) and has hyperkalemia (serum potassium level of 5.1 to greater than 6.5 mEq/L), that the member is stable on an angiotensin converting enzyme (ACE) inhibitor, angiotensin II receptor blocker (ARB), or an aldosterone antagonist (e.g. spironolactone, eplerenone)(if taking one of the medications), the patient has been counseled to take all other oral medications 3 hours before or 3 hours after Veltassa, Veltassa will not be used as an emergency treatment for life-threatening hyperkalemia, and the member is following a low potassium diet (less than or equal to 3 grams per day).
Age Restrictions
Prescriber Restrictions
Coverage Duration
1 year
Other Criteria
Reauthorization criteria: Use of Veltassa has been effective in treating hyperkalemia (e.g. current serum potassium level is lower than the pretreatment baseline serum potassium level), the member continues to require treatment for hyperkalemia, the member is stable on an angiotensin converting enzyme (ACE) inhibitor, angiotensin II receptor blocker (ARB), or an aldosterone antagonist (e.g. spironolactone, eplerenone)(if taking one of the medications) and the member continues to follow a low potassium diet (less than or equal to 3 grams per day).
Notes/References
2018 Aetna Premier Plus Plan01/01/2018
693
![Page 694: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/694.jpg)
Revision DatePrior Authorization: August 24, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
694
![Page 695: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/695.jpg)
Vemlidy
Products Affected• VEMLIDY
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/Vemlidy.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
695
![Page 696: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/696.jpg)
Venclexta
Products Affected• VENCLEXTA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Venclexta.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
696
![Page 697: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/697.jpg)
Venclexta Starting Pack
Products Affected• VENCLEXTA STARTING PACK
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Venclexta.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 1 pack Per 28 Days
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
697
![Page 698: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/698.jpg)
Ventavis
Products Affected• VENTAVIS
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CV/pulmonaryhypertensionagents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
698
![Page 699: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/699.jpg)
Verdrocet
Products Affected• VERDROCET
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
699
![Page 700: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/700.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
700
![Page 701: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/701.jpg)
Vicodin
Products Affected• VICODIN ORAL TABLET 5-300 MG
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
701
![Page 702: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/702.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
702
![Page 703: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/703.jpg)
Vicodin ES
Products Affected• VICODIN ES ORAL TABLET 7.5-300 MG
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
703
![Page 704: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/704.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
704
![Page 705: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/705.jpg)
Vicodin HP
Products Affected• VICODIN HP ORAL TABLET 10-300 MG
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
705
![Page 706: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/706.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
706
![Page 707: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/707.jpg)
Vicoprofen
Products Affected• VICOPROFEN
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
707
![Page 708: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/708.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
708
![Page 709: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/709.jpg)
Victrelis
Products Affected• VICTRELIS
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 12 capsules Per 1 Day
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
709
![Page 710: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/710.jpg)
Viekira Pak
Products Affected• VIEKIRA PAK
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
710
![Page 711: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/711.jpg)
Viekira XR
Products Affected• VIEKIRA XR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
711
![Page 712: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/712.jpg)
Vimizim
Products Affected• VIMIZIM
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/lysosomal_storage.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
712
![Page 713: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/713.jpg)
Visudyne
Products Affected• VISUDYNE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/EYE/ophthalmic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
713
![Page 714: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/714.jpg)
Voltaren
Products Affected• VOLTAREN TRANSDERMAL
QL Criteria 200 grams Per 30 Days
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
714
![Page 715: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/715.jpg)
Vonvendi
Products Affected• VONVENDI
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
715
![Page 716: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/716.jpg)
Vosevi
Products Affected• VOSEVI
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
716
![Page 717: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/717.jpg)
Votrient
Products Affected• VOTRIENT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
717
![Page 718: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/718.jpg)
Vpriv
Products Affected• VPRIV
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/gaucher_disease.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
718
![Page 719: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/719.jpg)
Vyvanse
Products Affected• VYVANSE
QL Criteria 2 capsules Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
719
![Page 720: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/720.jpg)
Vyvanse
Products Affected• VYVANSE
QL Criteria 2 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
720
![Page 721: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/721.jpg)
Wera
Products Affected• WERA
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
721
![Page 722: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/722.jpg)
Wilate
Products Affected• WILATE INTRAVENOUS KIT• WILATE INTRAVENOUS SOLUTION
RECONSTITUTED 1000-1000 UNIT, 500-500 UNIT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
722
![Page 723: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/723.jpg)
Xalkori
Products Affected• XALKORI
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 2 capsules Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
723
![Page 724: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/724.jpg)
Xartemis XR
Products Affected• XARTEMIS XR
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
724
![Page 725: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/725.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
725
![Page 726: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/726.jpg)
Xeljanz
Products Affected• XELJANZ
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Xeljanz_XeljanzXR.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
726
![Page 727: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/727.jpg)
Xeljanz XR
Products Affected• XELJANZ XR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/Xeljanz_XeljanzXR.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
727
![Page 728: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/728.jpg)
Xeloda
Products Affected• XELODA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
728
![Page 729: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/729.jpg)
Xenazine
Products Affected• XENAZINE ORAL TABLET 12.5 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/xenazine.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 4 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
729
![Page 730: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/730.jpg)
Xenazine
Products Affected• XENAZINE ORAL TABLET 25 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/xenazine.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 2 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
730
![Page 731: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/731.jpg)
Xeomin
Products Affected• XEOMIN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/botulinum_toxin.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
731
![Page 732: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/732.jpg)
Xermelo
Products Affected• XERMELO
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/Xermelo.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
732
![Page 733: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/733.jpg)
Xgeva
Products Affected• XGEVA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MUSC/bone_disease_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
733
![Page 734: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/734.jpg)
Xodol
Products Affected• XODOL
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
734
![Page 735: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/735.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
735
![Page 736: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/736.jpg)
Xolair
Products Affected• XOLAIR
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/RESP/Xolair.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
736
![Page 737: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/737.jpg)
Xtampza ER
Products Affected• XTAMPZA ER
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
737
![Page 738: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/738.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
738
![Page 739: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/739.jpg)
Xtandi
Products Affected• XTANDI
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
739
![Page 740: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/740.jpg)
Xuriden
Products Affected• XURIDEN
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/metabolic_agents.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
740
![Page 741: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/741.jpg)
Xyntha
Products Affected• XYNTHA INTRAVENOUS KIT 1000
UNIT, 2000 UNIT, 250 UNIT, 500 UNIT
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
741
![Page 742: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/742.jpg)
Xyntha Solofuse
Products Affected• XYNTHA SOLOFUSE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/bloodproducts_coagulants.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
742
![Page 743: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/743.jpg)
Xyrem
Products Affected• XYREM
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/cataplexy-xyrem.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
743
![Page 744: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/744.jpg)
Zamicet
Products Affected• ZAMICET
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
744
![Page 745: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/745.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
745
![Page 746: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/746.jpg)
Zarxio
Products Affected• ZARXIO
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/G-CSF.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
746
![Page 747: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/747.jpg)
Zavesca
Products Affected• ZAVESCA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/gaucher_disease.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
747
![Page 748: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/748.jpg)
Zejula
Products Affected• ZEJULA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Zejula.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
748
![Page 749: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/749.jpg)
Zelboraf
Products Affected• ZELBORAF
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 8 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
749
![Page 750: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/750.jpg)
Zemaira
Products Affected• ZEMAIRA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/Alpha-1 Antitrypsin Inhibitor Therapy.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
750
![Page 751: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/751.jpg)
Zenatane
Products Affected• ZENATANE
PA Criteria Criteria Details
Covered Uses Severe recalcitrant nodular or cystic acne
Exclusion Criteria
Required Medical Information
Member is enrolled in the FDA iPLEDGE program and, because of significant adverse reactions associated with its use, should be reserved for patients with multiple severe nodular acne who are unresponsive to conventional therapy, including topical acne products and systemic antibiotics
Age Restrictions
Prescriber Restrictions
Coverage Duration
1 year
Other Criteria
QL Criteria 2 capsules Per 1 Day
Notes/References
Annual Review: 02/2016
Revision DatePrior Authorization: August 22, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
751
![Page 752: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/752.jpg)
Zenchent
Products Affected• ZENCHENT
QL Criteria 1.5 tablet Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
752
![Page 753: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/753.jpg)
Zenzedi
Products Affected• ZENZEDI
QL Criteria 4 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
753
![Page 754: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/754.jpg)
Zepatier
Products Affected• ZEPATIER
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/GI/hepatitis_c.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: August 02, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
754
![Page 755: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/755.jpg)
Zinbryta
Products Affected• ZINBRYTA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/CNS/Zinbryta.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
755
![Page 756: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/756.jpg)
Zohydro ER
Products Affected• ZOHYDRO ER
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
756
![Page 757: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/757.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Annual Review: 06/2016
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
757
![Page 758: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/758.jpg)
Zohydro ER
Products Affected• ZOHYDRO ER
PA Criteria Criteria Details
Covered Uses All FDA approved indications
Exclusion Criteria
Required Medical Information
(1) A MEMBER WILL RECEIVE LIFETIME APPROVAL OF THE REQUESTED MEDICATION WHEN: Member is in hospice care, if terminally ill or has end-of-life care (other than hospice), or has an active oncology diagnosis (pain medication being used for pain for cancer patients) or palliative care. (2) FOR A DOCUMENTED DIAGNOSIS OF MODERATE TO SEVERE ACUTE PAIN (INCLUDING POST-SURGICAL PAIN), TRAUMATIC INJURY, OR FOR A CHILD ON AN OPIOID WEAN AT TIME OF HOSPITAL DISCHARGE: additional medication after initial coverage will be approved for up to 1 month. (3) FOR A DOCUMENTED DIAGNOSIS OF CHRONIC PAIN: which includes conditions of chronic pain not mentioned above, the prescriber must certify there is an active treatment plan that includes but is not limited to a specific treatment objective, the use of other pharmacological and non-pharmacological agents for pain relief as appropriate, that there has been an informed consent document signed and an addiction risk assessment performed, and that a written/signed agreement between prescriber and patient addressing issues of prescription management, diversion, and the use of other substances exists. When these criteria are met, the medication will be approved for an initial 3 months. Continuation requests may be approved for up to an additional 6 months.
Age Restrictions
Prescriber Restrictions
Coverage Duration
Length of Therapy; see required medical information
Other Criteria
2018 Aetna Premier Plus Plan01/01/2018
758
![Page 759: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/759.jpg)
QL Criteria 90 MME Per 1 Day
Notes/References
Annual Review: 06/2017
Revision DatePrior Authorization: September 06, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
759
![Page 760: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/760.jpg)
Zoladex
Products Affected• ZOLADEX
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/MISC/Gonadotropins.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
760
![Page 761: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/761.jpg)
Zolinza
Products Affected• ZOLINZA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 30 days maximum Per 1 fill
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
761
![Page 762: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/762.jpg)
Zomacton
Products Affected• ZOMACTON
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
762
![Page 763: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/763.jpg)
Zonalon
Products Affected• ZONALON
QL Criteria 45 grams Per 30 Days
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
763
![Page 764: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/764.jpg)
Zorbtive
Products Affected• ZORBTIVE
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ENDO/growthhormone.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
764
![Page 765: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/765.jpg)
Zovia 1/35E (28)
Products Affected• ZOVIA 1/35E (28)
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
765
![Page 766: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/766.jpg)
Zovia 1/50E (28)
Products Affected• ZOVIA 1/50E (28)
QL Criteria 1.5 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
766
![Page 767: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/767.jpg)
Zubsolv
Products Affected• ZUBSOLV SUBLINGUAL TABLET
SUBLINGUAL 1.4-0.36 MG, 5.7-1.4 MG
QL Criteria 90 tablets Per 30 Days
Notes/References
Annual Review: 04/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
767
![Page 768: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/768.jpg)
Zubsolv
Products Affected• ZUBSOLV SUBLINGUAL TABLET
SUBLINGUAL 11.4-2.9 MG
QL Criteria 1 tablet Per 1 Day
Notes/References
Annual Review: 04/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
768
![Page 769: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/769.jpg)
Zubsolv
Products Affected• ZUBSOLV SUBLINGUAL TABLET
SUBLINGUAL 2.9-0.71 MG
QL Criteria 3 tablets Per 1 Day
Notes/References
Annual Review: 04/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
769
![Page 770: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/770.jpg)
Zubsolv
Products Affected• ZUBSOLV SUBLINGUAL TABLET
SUBLINGUAL 8.6-2.1 MG
QL Criteria 2 tablets Per 1 Day
Notes/References
Annual Review: 04/2016
Revision DatePrior Authorization: August 25, 2015Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
770
![Page 771: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/771.jpg)
Zydelig
Products Affected• ZYDELIG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
771
![Page 772: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/772.jpg)
Zykadia
Products Affected• ZYKADIA
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
772
![Page 773: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/773.jpg)
Zytiga
Products Affected• ZYTIGA ORAL TABLET 250 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
QL Criteria 4 tablets Per 1 Day
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
773
![Page 774: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/774.jpg)
Zytiga
Products Affected• ZYTIGA ORAL TABLET 500 MG
PA Criteria Criteria Details
Covered Uses
Refer to the clinical policy bulletin for details: http://www.aetna.com/products/rxnonmedicare/data/2018/ANEOPL/Antineoplastics.html
Exclusion Criteria
Required Medical Information
Age Restrictions
Prescriber Restrictions
Coverage Duration
Refer to the clinical policy bulletin above for details.
Other Criteria
Notes/References
Revision DatePrior Authorization: September 26, 2017Step Therapy: August 25, 2015Quantity Limits: August 25, 2015
2018 Aetna Premier Plus Plan01/01/2018
774
![Page 775: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/775.jpg)
IndexIndex
ABSORICA................................................1ABSTRAL..................................................2acetaminophen-codeine ................................ 4acetaminophen-codeine #2 ...........................6acetaminophen-codeine #3 ...........................8acetaminophen-codeine #4 ......................... 10ACTEMRA..............................................12ACTIMMUNE........................................ 13ACTIQ..................................................... 14ADCIRCA............................................... 16ADDERALL............................................17ADDERALL XR..................................... 18ADEMPAS...............................................19ADVATE................................................. 20adynovate .................................................. 21ADZENYS XR-ODT...............................22AFINITOR.............................................. 23AFINITOR DISPERZ.............................24AFSTYLA................................................25ALDURAZYME..................................... 26ALECENSA.............................................27ALPHANATE/VWF COMPLEX/HUMAN..............................28ALPHANINE SD.................................... 29ALPROLIX..............................................30ALUNBRIG............................................ 31AMNESTEEM.........................................32amphetamine-dextroamphet er ...................33amphetamine-dextroamphetamine ..............34AMPYRA................................................ 35apap-caff-dihydrocodeine oral capsule ........36apap-caff-dihydrocodeine oral tablet 325-30-16 mg ................................................... 36APTENSIO XR........................................38ARALAST NP......................................... 39ARANESP (ALBUMIN FREE) INJECTION SOLUTION 10 MCG/0.4ML, 100 MCG/ML, 150 MCG/0.75ML, 200 MCG/ML, 25 MCG/ML, 300 MCG/ML, 40 MCG/ML, 60 MCG/ML.............................................40
Index
ARANESP (ALBUMIN FREE) INJECTION SOLUTION PREFILLED SYRINGE 100 MCG/0.5ML, 150 MCG/0.3ML, 200 MCG/0.4ML, 25 MCG/0.42ML, 300 MCG/0.6ML, 40 MCG/0.4ML, 500 MCG/ML, 60 MCG/0.3ML............................................ 40ARCALYST.............................................41ARYMO ER............................................ 42ASCOMP-CODEINE.............................. 44aspirin-caff-dihydrocodeine ........................46atomoxetine hcl oral capsule 10 mg, 18 mg, 25 mg, 40 mg, 60 mg ..................................48atomoxetine hcl oral capsule 100 mg, 80 mg .............................................................49AUBAGIO............................................... 50AUSTEDO...............................................51AVINZA ORAL CAPSULE EXTENDED RELEASE 24 HOUR 60 MG...........................................................52AVONEX.................................................54AVONEX PEN INTRAMUSCULAR AUTO-INJECTOR KIT.......................... 55AVONEX PREFILLED INTRAMUSCULAR PREFILLED SYRINGE KIT........................................ 56BEBULIN................................................ 57BEBULIN VH..........................................58BELBUCA............................................... 59BENEFIX INTRAVENOUS SOLUTION RECONSTITUTED........... 61BENLYSTA............................................. 62BERINERT..............................................63BETASERON SUBCUTANEOUS KIT. 64bexarotene .................................................65BIVIGAM................................................ 66BOSULIF.................................................67BOTOX.................................................... 68BRAVELLE............................................. 69BUNAVAIL BUCCAL FILM 2.1-0.3 MG...........................................................70
2018 Aetna Premier Plus Plan01/01/2018
775
![Page 776: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/776.jpg)
Index
BUNAVAIL BUCCAL FILM 4.2-0.7 MG...........................................................71BUNAVAIL BUCCAL FILM 6.3-1 MG.72BUPHENYL ORAL POWDER 3 GM/TSP................................................... 73BUPHENYL ORAL TABLET................ 73buprenorphine ............................................74buprenorphine hcl sublingual ...................... 76buprenorphine hcl-naloxone hcl ..................77butalbital-apap-caff-cod .............................78butalbital-asa-caff-codeine .........................80butorphanol tartrate nasal ..........................82BUTRANS...............................................84CABOMETYX.........................................86capecitabine ...............................................87CAPITAL/CODEINE..............................88CAPRELSA............................................. 90CARBAGLU........................................... 91CARIMUNE NF INTRAVENOUS SOLUTION RECONSTITUTED 12 GM, 6 GM................................................92CERDELGA............................................93CEREZYME............................................94CETROTIDE........................................... 95CHOLBAM..............................................96chorionic gonadotropin intramuscular ........ 97CIMZIA PREFILLED............................ 99CIMZIA STARTER KIT.......................100CIMZIA SUBCUTANEOUS KIT 2 X 200 MG.................................................... 98CINQAIR...............................................101CINRYZE.............................................. 102CLARAVIS............................................ 103clonidine hcl er .........................................104COAGADEX......................................... 105codeine sulfate oral tablet .........................106COMETRIQ (100 MG DAILY DOSE). 108COMETRIQ (140 MG DAILY DOSE). 109COMETRIQ (60 MG DAILY DOSE)... 110CONCERTA ORAL TABLET EXTENDED RELEASE 18 MG, 27 MG, 54 MG............................................111
Index
CONCERTA ORAL TABLET EXTENDED RELEASE 36 MG........... 112CONZIP................................................. 113COPAXONE SUBCUTANEOUS SOLUTION PREFILLED SYRINGE.. 115CORIFACT............................................116COSENTYX...........................................117COSENTYX SENSOREADY PEN SUBCUTANEOUS SOLUTION AUTO-INJECTOR 150 MG/ML....................... 118COTELLIC............................................ 119COTEMPLA XR-ODT.......................... 120CUPRIMINE ORAL CAPSULE 250 MG......................................................... 121CUVITRU..............................................122CYSTADANE........................................123CYSTARAN.......................................... 124DAKLINZA...........................................125DAYTRANA......................................... 126DEMEROL ORAL................................ 127DEPEN TITRATABS............................129DESCOVY............................................. 130DESOXYN.............................................131DEXEDRINE ORAL CAPSULE EXTENDED RELEASE 24 HOUR...... 132DEXEDRINE ORAL TABLET............ 133dexmethylphenidate hcl ............................134dexmethylphenidate hcl er oral capsule extended release 24 hour 10 mg, 20 mg, 30 mg ........................................................... 135dexmethylphenidate hcl er oral capsule extended release 24 hour 15 mg, 40 mg, 5 mg ........................................................... 135dextroamphetamine sulfate er .................. 138dextroamphetamine sulfate oral solution .. 136dextroamphetamine sulfate oral tablet ......137DIBENZYLINE.....................................139diclofenac sodium transdermal gel 1 % ..... 140diclofenac sodium transdermal gel 3 % ..... 141DILAUDID ORAL................................142DOLOPHINE........................................ 144doxepin hcl external .................................146DUPIXENT........................................... 147
2018 Aetna Premier Plus Plan01/01/2018
776
![Page 777: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/777.jpg)
Index
DURAGESIC-100..................................148DURAGESIC-12................................... 150DURAGESIC-25................................... 152DURAGESIC-50................................... 154DURAGESIC-75................................... 156DYANAVEL XR................................... 158DYSPORT............................................. 159ELAPRASE............................................160ELELYSO.............................................. 161ELIGARD..............................................162ELLA......................................................163ELOCTATE........................................... 164EMBEDA...............................................165EMFLAZA.............................................167EMLA.................................................... 168ENBREL SUBCUTANEOUS KIT....... 170ENBREL SUBCUTANEOUS SOLUTION PREFILLED SYRINGE 25 MG/0.5ML............................................. 170ENBREL SUBCUTANEOUS SOLUTION PREFILLED SYRINGE 50 MG/ML..................................................171ENBREL SURECLICK SUBCUTANEOUS SOLUTION AUTO-INJECTOR............................................ 172ENDOCET ORAL TABLET 10-325 MG, 2.5-325 MG, 5-325 MG, 7.5-325 MG......................................................... 173entecavir .................................................. 175ENTYVIO.............................................. 176EPCLUSA.............................................. 177EPOGEN INJECTION SOLUTION 10000 UNIT/ML, 2000 UNIT/ML, 20000 UNIT/ML, 3000 UNIT/ML, 4000 UNIT/ML...............................................178epoprostenol sodium .................................179ERIVEDGE........................................... 180ESBRIET ORAL CAPSULE................. 181ESBRIET ORAL TABLET....................182EUFLEXXA INTRA-ARTICULAR SOLUTION PREFILLED SYRINGE.. 183EVEKEO................................................184
Index
EXALGO ORAL TABLET ER 24 HOUR ABUSE-DETERRENT............. 185EXJADE.................................................187EXTAVIA SUBCUTANEOUS KIT......188EYLEA INTRAOCULAR.................... 189FABRAZYME.......................................190FALMINA............................................. 191FARYDAK............................................192FASLODEX INTRAMUSCULAR SOLUTION 250 MG/5ML.....................193FEIBA.................................................... 194FEIBA NF..............................................195FEIBA VH IMMUNO........................... 196fentanyl ................................................... 197fentanyl citrate buccal ..............................199FENTORA BUCCAL TABLET 100 MCG, 200 MCG, 400 MCG, 600 MCG, 800 MCG................................................ 201FERRIPROX......................................... 203FIORICET/CODEINE ORAL CAPSULE 50-300-40-30 MG................. 204FIORINAL/CODEINE #3.................... 206FIRAZYR.............................................. 208FIRMAGON..........................................209FLEBOGAMMA DIF........................... 211FLEBOGAMMA INTRAVENOUS SOLUTION 0.5 GM/10ML....................210FLOLAN................................................212FOCALIN.............................................. 213FOCALIN XR....................................... 214FOLLISTIM AQ.................................... 215FUZEON............................................... 216GAMMAGARD.................................... 217GAMMAGARD S/D INTRAVENOUS SOLUTION RECONSTITUTED 10 GM, 5 GM..............................................218GAMMAKED....................................... 219GAMMAPLEX INTRAVENOUS SOLUTION 10 GM/200ML, 2.5 GM/50ML, 20 GM/400ML, 5 GM/100ML............................................ 220GAMUNEX-C....................................... 221ganirelix acetate ...................................... 222
2018 Aetna Premier Plus Plan01/01/2018
777
![Page 778: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/778.jpg)
Index
GATTEX................................................223GEL-ONE INTRA-ARTICULAR PREFILLED SYRINGE....................... 224GELSYN-3.............................................225GENOTROPIN......................................226GENOTROPIN MINIQUICK.............. 227GILDAGIA............................................228GILDESS FE 1.5/30............................... 229GILDESS FE 1/20.................................. 230GILENYA..............................................231GILOTRIF.............................................232GLASSIA............................................... 233GLATOPA............................................. 234GLEEVEC..............................................235GONAL-F..............................................236GONAL-F RFF..................................... 237GONAL-F RFF PEN.............................238GONAL-F RFF REDIJECT................. 239GRANIX................................................240guanfacine hcl er ......................................241HAEGARDA.........................................242HARVONI............................................. 243HELIXATE FS...................................... 244HEMOFIL M INTRAVENOUS SOLUTION RECONSTITUTED 1000 UNIT, 1501-2000 UNIT, 1700 UNIT, 220-400 UNIT, 250 UNIT, 401-800 UNIT, 500 UNIT, 801-1500 UNIT.........245HETLIOZ...............................................246HIZENTRA SUBCUTANEOUS SOLUTION 1 GM/5ML, 10 GM/50ML, 2 GM/10ML, 4 GM/20ML..................... 247HP ACTHAR.........................................248HUMATE-P INTRAVENOUS SOLUTION RECONSTITUTED 1000-2400 UNIT, 250-600 UNIT, 500-1200 UNIT......................................................249HUMATROPE...................................... 250HUMIRA PEDIATRIC CROHNS START SUBCUTANEOUS PREFILLED SYRINGE KIT 40 MG/0.8ML............................................. 252
Index
HUMIRA PEN SUBCUTANEOUS PEN-INJECTOR KIT............................253HUMIRA PEN-CROHNS STARTER SUBCUTANEOUS PEN-INJECTOR KIT.........................................................254HUMIRA PEN-PSORIASIS STARTER SUBCUTANEOUS PEN-INJECTOR KIT.........................................................255HUMIRA SUBCUTANEOUS PREFILLED SYRINGE KIT............... 251HYALGAN............................................256HYCAMTIN ORAL..............................257HYCET.................................................. 258hydrocodone-acetaminophen oral solution10-325 mg/15ml, 2.5-108 mg/5ml, 5-217 mg/10ml, 7.5-325 mg/15ml ....................... 260hydrocodone-acetaminophen oral tablet 10-300 mg, 10-325 mg, 2.5-325 mg, 5-300 mg, 5-325 mg, 7.5-300 mg, 7.5-325 mg ............260hydrocodone-ibuprofen .............................262hydromorphone hcl er ...............................266hydromorphone hcl oral ........................... 264hydromorphone hcl rectal .........................264HYMOVIS............................................. 268HYQVIA................................................ 269HYSINGLA ER.....................................270IBRANCE.............................................. 272IBUDONE............................................. 273ICLUSIG................................................275IDELVION............................................ 276IDHIFA..................................................277ILARIS...................................................278ILARIS (150MG DELIVERED)........... 279imatinib mesylate .....................................280IMBRUVICA.........................................281INCRELEX............................................282INFERGEN........................................... 283INFLECTRA......................................... 284INGREZZA........................................... 285INLYTA.................................................286INTRON A............................................ 287INTUNIV...............................................288IRESSA.................................................. 289
2018 Aetna Premier Plus Plan01/01/2018
778
![Page 779: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/779.jpg)
Index
IXINITY................................................ 290JADENU................................................291JADENU SPRINKLE........................... 292JAKAFI..................................................293JETREA INTRAOCULAR...................294JUNEL 1.5/30.........................................295JUNEL 1/20............................................296JUNEL FE 1.5/30................................... 297JUNEL FE 1/20......................................298JUXTAPID ORAL CAPSULE 10 MG. 299JUXTAPID ORAL CAPSULE 20 MG. 300JUXTAPID ORAL CAPSULE 30 MG, 40 MG, 60 MG....................................... 301JUXTAPID ORAL CAPSULE 5 MG... 302KADIAN ORAL CAPSULE EXTENDED RELEASE 24 HOUR 10 MG, 100 MG, 20 MG, 30 MG, 50 MG, 60 MG, 80 MG....................................... 303KADIAN ORAL CAPSULE EXTENDED RELEASE 24 HOUR 200 MG, 40 MG, 70 MG...............................303KALBITOR........................................... 305KALYDECO ORAL PACKET............. 306KALYDECO ORAL TABLET..............307KANUMA............................................. 308KAPVAY ORAL................................... 309KAPVAY ORAL TABLET EXTENDED RELEASE 12 HOUR...... 310KARIVA................................................ 311KELNOR 1/35........................................312KEVEYIS...............................................313KEVZARA.............................................314KINERET SUBCUTANEOUS SOLUTION PREFILLED SYRINGE.. 315KISQALI 200 DOSE.............................. 316KISQALI 400 DOSE.............................. 317KISQALI 600 DOSE.............................. 318KISQALI FEMARA 200 DOSE............319KISQALI FEMARA 400 DOSE............320KISQALI FEMARA 600 DOSE............321KOATE.................................................. 322KOATE-DVI..........................................323KOGENATE FS.................................... 324
Index
KOGENATE FS BIO-SET.................... 325KORLYM.............................................. 326KOVALTRY..........................................327KRYSTEXXA........................................328KURVELO............................................ 329KUVAN................................................. 330KYNAMRO SUBCUTANEOUS SOLUTION PREFILLED SYRINGE.. 331LAZANDA............................................ 332LAZANDA............................................ 334LEENA...................................................335LEMTRADA......................................... 336LENVIMA 10 MG DAILY DOSE........ 337LENVIMA 14 MG DAILY DOSE........ 338LENVIMA 18 MG DAILY DOSE........ 339LENVIMA 20 MG DAILY DOSE........ 340LENVIMA 24 MG DAILY DOSE........ 341LENVIMA 8 MG DAILY DOSE.......... 342LESSINA............................................... 343LETAIRIS..............................................344LEUKINE..............................................345leuprolide acetate injection .......................346LEVONEST........................................... 347levonorgestrel-ethinyl estrad oral tablet0.15-30 mg-mcg ....................................... 348LEVORA 0.15/30 (28)............................ 349levorphanol tartrate oral .......................... 350lidocaine external ointment ...................... 352lidocaine-prilocaine external cream .......... 354LONSURF............................................. 356LORCET................................................ 357LORCET HD......................................... 359LORCET PLUS ORAL TABLET 7.5-325 MG...................................................361LORTAB ORAL ELIXIR 10-300 MG/15ML.............................................. 363LORTAB ORAL TABLET 10-325 MG, 5-325 MG, 7.5-325 MG...........................363LOW-OGESTREL................................. 365LUCENTIS INTRAOCULAR.............. 366LUCENTIS INTRAVITREAL SOLUTION PREFILLED SYRINGE.. 366LUMIZYME..........................................367
2018 Aetna Premier Plus Plan01/01/2018
779
![Page 780: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/780.jpg)
Index
LUPANETA PACK...............................368LUPRON DEPOT (1-MONTH)............369LUPRON DEPOT (3-MONTH)............370LUPRON DEPOT (4-MONTH)............371LUPRON DEPOT (6-MONTH)............372LUPRON DEPOT-PED (1-MONTH)...373LUPRON DEPOT-PED (3-MONTH)...374LUTERA................................................375LYNPARZA ORAL CAPSULE............376LYNPARZA ORAL TABLET.............. 377MACUGEN........................................... 378MAKENA..............................................379marlissa ................................................... 380MAVYRET............................................ 381MEKINIST............................................ 382MENOPUR............................................383meperidine hcl oral ...................................384METADATE CD................................... 386METADATE ER ORAL TABLET EXTENDED RELEASE 20 MG........... 387METHADONE HCL INTENSOL........ 390methadone hcl oral ...................................388METHADOSE ORAL CONCENTRATE 10 MG/ML...............392METHADOSE SUGAR-FREE.............394methamphetamine hcl .............................. 396METHYLIN ORAL SOLUTION 10 MG/5ML................................................ 397METHYLIN ORAL SOLUTION 5 MG/5ML................................................ 398METHYLIN ORAL TABLET CHEWABLE..........................................399methylphenidate hcl er (cd) ..................... 409methylphenidate hcl er (la) oral capsule extended release 24 hour 20 mg ................ 410methylphenidate hcl er (la) oral capsule extended release 24 hour 30 mg ................ 411methylphenidate hcl er (la) oral capsule extended release 24 hour 40 mg ................ 410methylphenidate hcl er (la) oral capsule extended release 24 hour 60 mg ................ 412methylphenidate hcl er oral tablet extended release 10 mg ........................................... 403
Index
methylphenidate hcl er oral tablet extended release 18 mg, 27 mg, 54 mg .....................404methylphenidate hcl er oral tablet extended release 20 mg ........................................... 405methylphenidate hcl er oral tablet extended release 24 hour 18 mg, 27 mg, 54 mg ........ 407methylphenidate hcl er oral tablet extended release 24 hour 36 mg ...............................408methylphenidate hcl er oral tablet extended release 36 mg ........................................... 406methylphenidate hcl oral solution 10 mg/5ml .................................................... 400methylphenidate hcl oral solution 5 mg/5ml................................................................ 401methylphenidate hcl oral tablet .................402methylphenidate hcl oral tablet chewable ..402MICROGESTIN 1.5/30..........................413MICROGESTIN 1/20............................ 414MICROGESTIN FE 1.5/30....................415MICROGESTIN FE 1/20.......................416MIRCERA INJECTION SOLUTION PREFILLED SYRINGE....................... 417MONOCLATE-P................................... 418MONONINE......................................... 419MONOVISC...........................................420MORPHABOND ER.............................421morphine sulfate (concentrate) oral solution 100 mg/5ml, 20 mg/ml .................425morphine sulfate er beads ......................... 429morphine sulfate er oral capsule extended release 24 hour .........................................427morphine sulfate er oral tablet extended release ..................................................... 427morphine sulfate oral ............................... 423morphine sulfate rectal .............................423MS CONTIN ORAL TABLET EXTENDED RELEASE....................... 431MYALEPT.............................................433MYDAYIS............................................. 434MYORISAN.......................................... 435MYORISAN.......................................... 436MYOZYME........................................... 437NAGLAZYME...................................... 438
2018 Aetna Premier Plus Plan01/01/2018
780
![Page 781: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/781.jpg)
Index
NATPARA.............................................439NECON 0.5/35 (28)................................ 440NECON 1/35 (28)................................... 441NECON 10/11 (28)................................. 442NERLYNX............................................ 443NEULASTA DELIVERY KIT SUBCUTANEOUS PREFILLED SYRINGE KIT...................................... 445NEULASTA SUBCUTANEOUS SOLUTION PREFILLED SYRINGE.. 444NEUMEGA........................................... 446NEUPOGEN INJECTION SOLUTION 300 MCG/ML, 480 MCG/1.6ML........... 447NEUPOGEN INJECTION SOLUTION PREFILLED SYRINGE....................... 447NEXAVAR............................................ 448NINLARO............................................. 449NITYR................................................... 450NORCO..................................................451NORDITROPIN FLEXPRO SUBCUTANEOUS SOLUTION 10 MG/1.5ML, 15 MG/1.5ML, 5 MG/1.5ML............................................. 453NORDITROPIN NORDIFLEX PEN SUBCUTANEOUS SOLUTION 30 MG/3ML................................................ 454norgestrel-ethinyl estradiol .......................455NORTHERA ORAL CAPSULE 100 MG......................................................... 456NORTHERA ORAL CAPSULE 200 MG, 300 MG.......................................... 457NORTREL 0.5/35 (28)........................... 458NORTREL 1/35 (21).............................. 459NORTREL 1/35 (28).............................. 460novarel intramuscular solution reconstituted 10000 unit ........................... 461NOVOEIGHT........................................ 462NOVOSEVEN RT..................................463NPLATE................................................ 464NUCALA...............................................465NUCYNTA............................................466NUCYNTA ER......................................468NUPLAZID........................................... 470
Index
NUTROPIN AQ.................................... 472NUTROPIN AQ NUSPIN 10................473NUTROPIN AQ NUSPIN 20................474NUTROPIN AQ NUSPIN 5..................475NUTROPIN AQ PEN............................476NUTROPIN SUBCUTANEOUS SOLUTION RECONSTITUTED 10 MG......................................................... 471NUWIQ INTRAVENOUS KIT 1000 UNIT, 2000 UNIT, 250 UNIT, 500 UNIT......................................................477NUWIQ INTRAVENOUS SOLUTION RECONSTITUTED 1000 UNIT, 2000 UNIT, 250 UNIT, 500 UNIT................. 477OCALIVA ORAL TABLET 5 MG........478OCTAGAM........................................... 479octreotide acetate .....................................480ODOMZO.............................................. 481OFEV..................................................... 482OLYSIO................................................. 483OMNITROPE........................................ 484OPANA ER ORAL TABLET ER 12 HOUR ABUSE-DETERRENT............. 487OPANA ORAL...................................... 485OPSUMIT.............................................. 489ORENCIA CLICKJECT....................... 492ORENCIA INTRAVENOUS................ 490ORENCIA SUBCUTANEOUS SOLUTION PREFILLED SYRINGE 125 MG/ML........................................... 491ORENCIA SUBCUTANEOUS SOLUTION PREFILLED SYRINGE 50 MG/0.4ML, 87.5 MG/0.7ML................. 490ORENITRAM....................................... 493ORFADIN ORAL CAPSULE 10 MG, 2 MG, 5 MG..............................................494ORFADIN ORAL SUSPENSION........ 494ORKAMBI.............................................495ORSYTHIA........................................... 496ORTHOVISC INTRA-ARTICULAR SOLUTION PREFILLED SYRINGE.. 497OTEZLA ORAL TABLET.................... 498
2018 Aetna Premier Plus Plan01/01/2018
781
![Page 782: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/782.jpg)
Index
OTEZLA ORAL TABLET THERAPY PACK..................................................... 498OVIDREL.............................................. 499OXAYDO...............................................500oxycodone hcl er oral tablet er 12 hour abuse-deterrent ........................................ 504oxycodone hcl er oral tablet er 12 hour abuse-deterrent ........................................ 506oxycodone hcl oral capsule .......................502oxycodone hcl oral concentrate 100 mg/5ml................................................................ 502oxycodone hcl oral concentrate 20 mg/ml . 502oxycodone hcl oral solution ...................... 502oxycodone hcl oral tablet ......................... 502oxycodone-acetaminophen oral solution ... 508oxycodone-acetaminophen oral tablet 10-325 mg, 2.5-325 mg, 5-325 mg, 7.5-325 mg................................................................ 508oxycodone-aspirin oral tablet 4.8355-325 mg ........................................................... 510oxycodone-ibuprofen ................................512OXYCONTIN ORAL TABLET ER 12 HOUR ABUSE-DETERRENT............. 514oxymorphone hcl ......................................516oxymorphone hcl er ..................................518OZURDEX INTRAOCULAR.............. 520PEGASYS.............................................. 521PEGASYS PROCLICK......................... 522PEGINTRON........................................ 523PEG-INTRON....................................... 524PEG-INTRON REDIPEN.....................525PEG-INTRON REDIPEN PAK 4......... 526pentazocine-naloxone hcl ......................... 527PERCOCET ORAL TABLET 10-325 MG, 2.5-325 MG, 5-325 MG, 7.5-325 MG......................................................... 529phenoxybenzamine hcl oral ...................... 531PHILITH................................................532PLEGRIDY........................................... 533PLEGRIDY STARTER PACK.............534POMALYST.......................................... 535PORTIA-28............................................ 536PRALUENT.......................................... 537
Index
pregnyl .................................................... 538PRIMLEV.............................................. 539PRIVIGEN.............................................541PROCENTRA........................................542PROCRIT.............................................. 543PROCYSBI ORAL CAPSULE DELAYED RELEASE 25 MG..............544PROCYSBI ORAL CAPSULE DELAYED RELEASE 75 MG..............545PROFILNINE SD..................................546PROLASTIN-C INTRAVENOUS SOLUTION RECONSTITUTED 1000 MG......................................................... 547PROLIA................................................. 548PROMACTA......................................... 549PRUDOXIN.......................................... 550PULMOZYME...................................... 551PURIXAN..............................................552QUILLICHEW ER ORAL TABLET CHEWABLE EXTENDED RELEASE 20 MG, 40 MG....................................... 553QUILLICHEW ER ORAL TABLET CHEWABLE EXTENDED RELEASE 30 MG.................................................... 554QUILLIVANT XR.................................555RAVICTI............................................... 556REBIF REBIDOSE SUBCUTANEOUS SOLUTION AUTO-INJECTOR........... 558REBIF REBIDOSE TITRATION PACK SUBCUTANEOUS SOLUTION AUTO-INJECTOR................................ 559REBIF SUBCUTANEOUS SOLUTION PREFILLED SYRINGE....................... 557REBIF TITRATION PACK SUBCUTANEOUS SOLUTION PREFILLED SYRINGE....................... 560RECLIPSEN.......................................... 561RECOMBINATE...................................562REMICADE.......................................... 563REMODULIN....................................... 564RENFLEXIS..........................................565REPATHA............................................. 566REPATHA PUSHTRONEX SYSTEM.567
2018 Aetna Premier Plus Plan01/01/2018
782
![Page 783: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/783.jpg)
Index
REPATHA SURECLICK......................568REPREXAIN ORAL TABLET 10-200 MG, 5-200 MG....................................... 569REPRONEX.......................................... 571REVATIO INTRAVENOUS.................572REVATIO ORAL SUSPENSION RECONSTITUTED...............................573REVATIO ORAL TABLET.................. 574REVLIMID............................................575RIASTAP............................................... 576RITALIN............................................... 577RITALIN LA ORAL CAPSULE EXTENDED RELEASE 24 HOUR 10 MG, 20 MG, 40 MG, 60 MG................. 578RITALIN LA ORAL CAPSULE EXTENDED RELEASE 24 HOUR 30 MG......................................................... 579RIXUBIS................................................580rosuvastatin calcium .................................581ROXICET ORAL SOLUTION............. 582ROXICODONE ORAL TABLET......... 584RUBRACA............................................ 586RUCONEST.......................................... 587RYDAPT................................................588SABRIL..................................................589SAIZEN..................................................590SAIZEN CLICK.EASY......................... 591SAMSCA................................................592SANDOSTATIN....................................593SANDOSTATIN LAR DEPOT.............594SEROSTIM SUBCUTANEOUS SOLUTION RECONSTITUTED 4 MG, 5 MG, 6 MG........................................... 595SIGNIFOR.............................................596SIGNIFOR LAR INTRAMUSCULAR SUSPENSION RECONSTITUTED..... 597sildenafil citrate oral ................................ 598SILIQ......................................................599SIMPONI ARIA.................................... 601SIMPONI SUBCUTANEOUS SOLUTION AUTO-INJECTOR........... 600SIMPONI SUBCUTANEOUS SOLUTION PREFILLED SYRINGE.. 600
Index
SIRTURO.............................................. 602sodium phenylbutyrate oral powder 3 gm/tsp ......................................................603SOLARAZE........................................... 604SOLIRIS.................................................605SOMATULINE DEPOT........................606SOMAVERT.......................................... 607SOVALDI.............................................. 608SPRYCEL.............................................. 609SRONYX............................................... 610STELARA INTRAVENOUS................ 611STELARA SUBCUTANEOUS SOLUTION PREFILLED SYRINGE.. 611STIOLTO RESPIMAT.......................... 612STIVARGA............................................613STRATTERA ORAL CAPSULE 10 MG, 18 MG, 25 MG, 40 MG, 60 MG.... 614STRATTERA ORAL CAPSULE 100 MG, 80 MG............................................615STRENSIQ.............................................616SUBOXONE SUBLINGUAL FILM 12-3 MG...................................................... 617SUBOXONE SUBLINGUAL FILM 2-0.5 MG, 4-1 MG, 8-2 MG.......................618SUBOXONE SUBLINGUAL TABLET SUBLINGUAL...................................... 619SUBSYS................................................. 620SUPARTZ INTRA-ARTICULAR SOLUTION PREFILLED SYRINGE.. 622SUPPRELIN LA....................................623SUTENT................................................ 624SYLATRON SUBCUTANEOUS KIT 200 MCG, 300 MCG, 4 X 200 MCG, 4 X 300 MCG, 600 MCG.............................. 625SYNAGIS...............................................626SYNALGOS-DC....................................627SYNAREL............................................. 629SYNVISC INTRA-ARTICULAR SOLUTION PREFILLED SYRINGE.. 630SYNVISC ONE INTRA-ARTICULAR SOLUTION PREFILLED SYRINGE.. 631SYPRINE...............................................632tacrolimus external .................................. 633
2018 Aetna Premier Plus Plan01/01/2018
783
![Page 784: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/784.jpg)
Index
TAFINLAR........................................... 634TAGRISSO............................................ 635TALTZ................................................... 636TARCEVA............................................. 637TARGRETIN ORAL............................ 638TASIGNA.............................................. 639TECFIDERA ORAL............................. 640TECFIDERA ORAL CAPSULE DELAYED RELEASE 120 MG............ 641TECFIDERA ORAL CAPSULE DELAYED RELEASE 240 MG............ 642TECHNIVIE.......................................... 643TEMODAR ORAL................................644temozolomide ...........................................645tetrabenazine ........................................... 646TEV-TROPIN........................................ 647THALOMID.......................................... 648THIOLA.................................................649TILIA FE............................................... 650TRACLEER...........................................651tramadol hcl er .........................................654tramadol hcl er (biphasic) ........................656tramadol hcl oral ..................................... 652tramadol-acetaminophen ..........................658TRELSTAR........................................... 660TRELSTAR MIXJECT......................... 661TREMFYA............................................ 662TRETTEN..............................................663TREZIX ORAL CAPSULE 320.5-30-16 MG......................................................... 664TRI-LEGEST FE................................... 666TRIVORA (28).......................................667TRUVADA............................................ 668TYKERB................................................669TYLENOL WITH CODEINE #3..........670TYLENOL WITH CODEINE #4..........672TYMLOS............................................... 674TYSABRI...............................................675TYVASO................................................ 676TYVASO REFILL................................. 677TYVASO STARTER............................. 678ULTRACET...........................................679ULTRAM.............................................. 681
Index
ULTRAM ER ORAL TABLET EXTENDED RELEASE 24 HOUR 100 MG, 300 MG.......................................... 683UPTRAVI.............................................. 685VALCHLOR.......................................... 686VALCYTE............................................. 687valganciclovir hcl ..................................... 688VANTAS................................................689VECAMYL............................................ 690VELETRI............................................... 691VELIVET............................................... 692VELTASSA............................................ 693VEMLIDY............................................. 695VENCLEXTA........................................696VENCLEXTA STARTING PACK....... 697VENTAVIS............................................ 698VERDROCET........................................699VICODIN ES ORAL TABLET 7.5-300 MG......................................................... 703VICODIN HP ORAL TABLET 10-300 MG......................................................... 705VICODIN ORAL TABLET 5-300 MG..701VICOPROFEN...................................... 707VICTRELIS........................................... 709VIEKIRA PAK...................................... 710VIEKIRA XR........................................ 711VIMIZIM............................................... 712VISUDYNE........................................... 713VOLTAREN TRANSDERMAL...........714VONVENDI...........................................715VOSEVI..................................................716VOTRIENT............................................717VPRIV.................................................... 718VYVANSE............................................. 719VYVANSE............................................. 720WERA.................................................... 721WILATE INTRAVENOUS KIT........... 722WILATE INTRAVENOUS SOLUTION RECONSTITUTED 1000-1000 UNIT, 500-500 UNIT.........................................722XALKORI............................................. 723XARTEMIS XR.....................................724XELJANZ.............................................. 726
2018 Aetna Premier Plus Plan01/01/2018
784
![Page 785: 2018 Aetna Premier Plus Plan - Lee County, Florida](https://reader035.vdocuments.us/reader035/viewer/2022081701/62e417e89a6ac0725813a36b/html5/thumbnails/785.jpg)
Index
XELJANZ XR....................................... 727XELODA............................................... 728XENAZINE ORAL TABLET 12.5 MG 729XENAZINE ORAL TABLET 25 MG... 730XEOMIN................................................731XERMELO............................................ 732XGEVA..................................................733XODOL..................................................734XOLAIR.................................................736XTAMPZA ER...................................... 737XTANDI................................................ 739XURIDEN............................................. 740XYNTHA INTRAVENOUS KIT 1000 UNIT, 2000 UNIT, 250 UNIT, 500 UNIT......................................................741XYNTHA SOLOFUSE..........................742XYREM................................................. 743ZAMICET..............................................744ZARXIO.................................................746ZAVESCA..............................................747ZEJULA.................................................748ZELBORAF...........................................749ZEMAIRA............................................. 750ZENATANE.......................................... 751ZENCHENT.......................................... 752ZENZEDI.............................................. 753ZEPATIER.............................................754ZINBRYTA........................................... 755ZOHYDRO ER......................................756ZOHYDRO ER......................................758ZOLADEX.............................................760ZOLINZA.............................................. 761ZOMACTON......................................... 762ZONALON............................................ 763ZORBTIVE............................................ 764ZOVIA 1/35E (28)...................................765ZOVIA 1/50E (28)...................................766ZUBSOLV SUBLINGUAL TABLET SUBLINGUAL 1.4-0.36 MG, 5.7-1.4 MG......................................................... 767ZUBSOLV SUBLINGUAL TABLET SUBLINGUAL 11.4-2.9 MG................. 768
Index
ZUBSOLV SUBLINGUAL TABLET SUBLINGUAL 2.9-0.71 MG................. 769ZUBSOLV SUBLINGUAL TABLET SUBLINGUAL 8.6-2.1 MG...................770ZYDELIG.............................................. 771ZYKADIA............................................. 772ZYTIGA ORAL TABLET 250 MG.......773ZYTIGA ORAL TABLET 500 MG.......774
2018 Aetna Premier Plus Plan01/01/2018
785